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ABSTRACT 
The primary marketing strategy in the oat industry is to emphasize the health benefits that 
oats provide to a healthy human diet. Avenanthramides (AVNs) are a group of phytochemicals, 
which are unique to oats among cereal grains that provide health benefits through antioxidant 
activity among other biological activities. While approximately forty AVNs have been identified 
from oat extracts, three AVNs account for the majority of the total concentration. Those three 
AVNs are known as AVN 2p, AVN 2f, and AVN 2c and are the focus of this research. There is 
currently limited information on how avenanthramides interact with pathogens, the regional 
genotype-by-environment interactions of AVN concentration, and the heritability of AVN 
concentration. 
This study explored the relationship between Barley Yellow Dwarf Virus (BYDV) and 
avenanthramide concentration, as well as the genotype-by-environment interaction and 
heritability for avenanthramide concentrations in Illinois. One hundred genotypes were evaluated 
for BYDV tolerance and AVN concentration to investigate if a relationship exists between the 
two traits. Based on the data collected in 2017 and 2018, a significant correlation between 
BYDV tolerance and AVN concentration was not observed.  Avenanthramide concentrations 
were quantified for the same 100 genotypes at three environments in two years to determine if 
environmental factors influence AVNs and if AVNs were heritable. The collected data, 
suggested that while year and environment had an influence on AVN concentrations, with the 
influence of year being more apparent than that of environment within a year, genotype had the 
largest impact on genotypic performance for the traits. When heritability was estimated the three 
major AVNs were found to be heritable.  
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CHAPTER 1: LITERATURE REVIEW 
 INTRODUCTION TO RESEARCH AND OBJECTIVES 
Oat groats provide a good source of carbohydrates, fiber, lipids, and balanced proteins, as 
well as, several vitamins, making oats an ideal component of the human diet. The U.S Food and 
Drug Administration has approved health claims that are associated with 𝛽-glucans, which is the 
main source of soluble dietary fiber in oats (Martínez-Villaluenga & Peñas, 2017), but 𝛽-glucans 
are not the only nutritional compounds in spring oat of interest to the research community. 
Avenanthramides (AVNs) are a group of nutritional compounds that are unique to oats among 
cereal grains, and are believed to account for a large portion of the antioxidant properties of the 
species (Chen, Milbury, Collins, & Blumberg, 2007; Peterson, Hahn, & Emmons, 2002). The 
beneficial impacts of AVNs on human health when AVNs are included in the diet, the 
antioxidant ability, and the other biological activities of AVNs suggest that research on AVNs 
could yield valuable information and stimulated our interest in this research. Many different 
AVNs can be found in spring oats; however, there are three AVNs that account for the majority 
of the grain AVN concentration. These avenanthramides are AVN 2c, AVN 2p, and AVN 2f (M. 
L. Wise, Doehlert, & McMullen, 2008) and will be the focus of this research. While there has 
been research that looked into the phenotypic expression of avenanthramides, this work has been 
limited in geographical region, study size, and the number of factors considered. There has been 
a significant amount of research into the relationship of grain AVN concentration and the fungal 
disease crown rust (caused by Puccinia coronata Corda var. avenae), which has resulted in the 
discovery of a correlation between crown rust tolerance and increased grain AVN concentration 
(Peterson, Wesenberg, Burrup, & Erickson, 2005; M. L. Wise et al., 2008). This relationship 
between crown rust and increased AVN concentration is another reason this research was of 
interest. Another important disease in spring oat is barley yellow dwarf (BYD), and based on the 
published literature little to no research has been conducted to investigate if a relationship similar 
to the one just described exists between BYD tolerance and grain AVN concentration. BYD is 
also of interest in relation to AVNs as AVNs have been shown to increase in concentration with 
general stress (Peterson et al., 2005), and BYD causes stress on infected genotypes. If a 
relationship does exist between these two traits BYD tolerance could perhaps be used as an 
indirect selection method for grain AVN concentration, this would be beneficial as phenotyping 
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AVN concentration is a time-consuming process. In addition to any potential relationship to 
BYD tolerance, the overall diversity of AVN concentration in the small grains oat breeding 
program at the University of Illinois Urbana-Champaign (UIUC) is of great interest. In order to 
initiate an effective selection method for increased AVN concentration there must first be 
diversity in the germplasm for the trait of interest. Preliminary data suggested that some 
genotypes in the UIUC oat breeding program contain high concentrations of AVNs. While few 
of the breeding lines from the program have been phenotyped for AVN concentration prior to 
this study, one genotype (IL09_6937) that was phenotyped was found to have AVN 
concentration levels of approximately 300 𝜇𝑔/𝑔, which is at the high end of known range of 
AVNs in spring oat. It should be noted that IL09_6937 was only evaluated for AVN 
concentration at one location for two years. The genotype-by-environment effect on AVN 
concentration and the heritability of AVN concentration are also of interest as both of these have 
a large impact on the success of selection. In summary, my objectives in this research were to 
determine if a relationship exists between grain AVN concentration and BYD tolerance, and to 
assess the overall diversity of grain AVN concentration of the Illinois oat breeding program at 
UIUC, the genotype-by-environment effect on AVN concentration, and the heritability of AVN 
concentration. 
Based on research conducted, the benefits of AVNs appear to be dosage dependent. 
Therefore, the identification of breeding lines with substantially higher AVN concentrations 
could lead to the development of oat cultivar with higher concentrations of AVNs, which could 
be quite beneficial since consumers would realize increased health benefits from the same 
amount of oat consumption. This research on the diversity of AVN concentration and factors, 
such as BYD, that influence AVN concentration is one of the first steps toward that longer term 
goal. 
SPRING OAT 
GENETIC HISTORY 
During the development of early agriculture around the world, oats were a crop of 
importance (Martínez-Villaluenga & Peñas, 2017; Winkler et al., 2016). Spring oat (Avena sativa 
L.) belongs to the genus Avena within the family Poaceae (Jing & Hu, 2012). There are 
approximately seventy species of oats with only a few being cultivated (Jing & Hu, 2012). Some 
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of the cultivated oat species include A. sativa, A. byzantina, A. fatua, A. diffusa and A. orientalis 
(Jing & Hu, 2012). Of these cultivated species of oats, A. sativa and A. byzantina are primarily 
the two species that are grown commercially (Jing & Hu, 2012). Of these two species A. sativa  
is most important due to its nutrition characteristics (Jing & Hu, 2012). Species in the Avena 
genus are closely related and share their genomes with each other, this leads to the presumption 
that some species in the genus are the ancestors of others (Linares, Ferrer, & Fominaya, 1998). 
The genus is composed of diploids, tetraploids, and hexaploids (Q. Liu, Lin, Zhou, Peterson, & 
Wen, 2017). Diploids contain the A- and C-genomes, tetraploids contain the AB- and A’C (now 
known as DC)-genome, and hexaploids contain the ACD-genomes. The C-genome is relatively 
easy  to distinguish from the other genomes (Q. Liu et al., 2017), while the A-, B-, and D-
genomes have proved to be more difficult to distinguish from one another (Katsiotis, Loukas, & 
Heslop-Harrison, 2000). Avena sativa L. belongs to the hexaploid group in the Avena genus, as it 
is an allohexaplod (Linares et al., 1998; Q. Liu et al., 2017). Spring oat is believed to have 
developed through ancient alleotetraploidy events in which the ancient A’-genome diploid 
ancestors hybridized with the C-genome diploid ancestors to form the DC-genome tetraploids 
(Q. Liu et al., 2017). These ancient alleotetraploidy events were followed by allohexaploidy 
events in which the DC-genome tetraploids hybridized with the more recent A-genome diploid 
progenitors to form the ACD-genome hexaploids (Q. Liu et al., 2017).  
POPULATION STRUCTURE 
While the events that led to the allohexaploid A. sativa species have begun to be 
elucidated, there are still large gaps in the our knowledge of the oat genome due to an 
underinvestment in the genetic analysis of oats compared with other crops. Souza and Sorrells 
(1989) conducted a survey on the genetic diversity of 205 North American oat cultivars released 
between 1951 and 1986. Using principal component analysis the 205 cultivars were clustered 
based on the relative contributions of ancestral parents and the average cultivar coefficient-of-
parentage values, which infer the covariance of alleles between genotypes by estimating the 
average number of loci that are identical by descent, within and between clusters (Souza & 
Sorrells, 1989).  Principal component analysis is a statistical tool that is used to assess the 
diversity and population structure of germplasm pools, with each cluster or principal component 
explaining a percentage of the total variation. Souza and Sorrells (1989) found that the first three 
principal components accounted for 32.6% of the variation in the coefficient-of-parentage values 
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of the cultivars released between 1951 and 1960, and 27.1% of the variation in the coefficient-of-
parentage values of the cultivars released between 1976 and 1985. This change in coefficient-of-
parentage values between time periods indicates that the North American germplasm pool has 
changed through time (Souza & Sorrells, 1989). A total of seven clusters were formed to 
describe the relationship between ancestral parents and recent cultivars in the Souza and Sorrells 
(1989) survey. Two of the oat cultivars that are used in the current study were included in the 
Souza and Sorrells (1989) survey. The cultivar Ogle fell into the largest of the clusters, the 
Central cluster. The Central cluster primarily included most of the older midseason spring oat 
cultivars of the time and most of the newer oat cultivars of the time (Souza & Sorrells, 1989). 
The second cultivar, Clintland 64, fell into the Landhafer cluster which contained several 
important older cultivars (Souza & Sorrells, 1989). It should be noted that one of the 
assumptions for estimations of coefficient-of-parentage is the there is no selection, which is not 
always a realistic assumption, and an assumption that was not met in the study discussed above. 
In comparison, O’Donoughue et al. (1994) conducted a principal component analysis using 
restriction fragment length polymorphisms (RFLPs) on 83 oat cultivars that were representative 
of the North American germplasm at the time. The first three principal components accounted 
for 63.7% of the genetic variation as captured by the RFLPs (O’Donoughue, Souza, Tanksley, & 
Sorrells, 1994). The first principal component in the O’Donoughue et al. (1994) study divided 
the 83 oat cultivars into spring and winter types, which is most likely due to the different sources 
of germplasm that contribute to the two groups (O’Donoughue et al., 1994).  Winkler et al. 
(2016) performed a study of a more world-wide scope than the Souza and Sorrells (1989) and the 
O’Donoughue et al (1994) studies. The Winkler et al. (2016) study used 759 A. sativa accessions 
of temporally and geographically diverse background that had been subjected to little to no 
selection pressure to conduct a principal component analysis. The first three principal 
components accounted for 38.8% of the genetic variation as captured by single nucleotide 
polymorphisms (Winkler et al., 2016). These first three principal components were largely 
explained by region of origin of the cultivars. Winkler et al. (2016) found that the first principal 
component was primarily from Western Asia, Southern Europe, and Northern Africa in origin; 
while, the second principal component was found to be characterized as widely distributed across 
Central Asia and Europe in origin. The third principal component originated predominantly from 
Europe and North American (Winkler et al., 2016). Principal component one was genetically 
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distant from principal components two and three, suggesting that it was largely unused by 
twentieth century breeding and could hold valuable genetic material for future breeding (Winkler 
et al., 2016). In general, understanding the genetic diversity and population structure within a 
species is an invaluable tool for plant breeders. 
HEALTH BENEFITS 
The underinvestment in research on oats may be partially due to the fact that oat 
production has declined over the past several decades. In 1950 there were 3,796,000 acres of oats 
harvested in Illinois (Illinois Department of Agriculture, n.d.), by 1980 the total land area of oats 
harvested for grain purposes in Illinois had dropped to 230,000 acres (Illinois Department of 
Agriculture, n.d.), which is still significantly larger than 2017 when a total of 20,000 acres of 
oats were harvested in Illinois (USDA-NASS, 2018). Despite the decrease in oat production, 
there is still a demand for high-quality oats for human consumption. Oats have regained interest 
due to the health benefits that have been elucidated with the development of modern food and 
nutritional science technologies. The health benefits associated with oats are in part due to the 
fact that oats are a nutritious addition to the human diet as a whole grain. Where grain crops are 
concerned, the ideal composition for human nutrition is high protein and soluble fiber 
concentrations combined with low oil concentration (Peterson et al., 2005). The kernels of oats 
can be divided into two major anatomical features, the groat and the hull. The groat is comprised 
of the bran, endosperm, and embryo which is what remains of the oat kernel once the hull, which 
is a leaf-like structure that surround the groat, is removed. The groat is the portion of the kernel 
that is consumed by humans. Oat groats typically account for 65% to 85% of the oat kernel and 
are composed of 12.0% to 25.0% protein (Hareland & Manthey, 2003), 10% to 12.1%  dietary 
fiber, and 6.21% to 8.6% lipids (Jing & Hu, 2012).  
In addition to the well-balanced macronutrients that oats provide, they are also a good 
source of B vitamins and minerals. Some of the minerals present in oats include calcium, iron, 
magnesium, potassium, zinc and manganese (Jing & Hu, 2012). The primary marketing 
campaign for oats involves the heart healthy claim. This health claim, which has been approved 
by the United States Food and Drug Administration (USDA) and the European Food and Safety 
Agency, stems primarily from the properties of 𝛽-glucan (Martínez-Villaluenga & Peñas, 2017). 
Beta-glucans account for at least 78% of the soluble fiber in oats (Jing & Hu, 2012), and are 
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linear unbranched chains of D-glucose molecules (Martínez-Villaluenga & Peñas, 2017). There 
is strong evidence that 𝛽-glucans are at least partially responsible for the serum cholesterol-
lowering effect that has been attributed to oat and other whole grain consumption. One suggested 
mechanism by which 𝛽-glucans lower cholesterol levels is through the interference of the 
absorption of bile acids and fats (Jing & Hu, 2012). This interference increases bile acid 
synthesis from serum cholesterol (Jing & Hu, 2012) through the upregulation of cholesterol 7-𝛼 
hydroxylase, ultimately lowering the circulating low-density lipoprotein (LDL) cholesterol 
(Martínez-Villaluenga & Peñas, 2017). This cholesterol lowering mechanism has been attributed 
to the viscosity of 𝛽-glucans. Beta-glucans’ viscosity is influenced by the molecular weight, 
molecular structure, and concentration of the 𝛽-glucan molecules. The dose range of 𝛽-glucan 
intake that can produce a small but significant reduction in serum and LDL cholesterol is 2 to 10 
grams of oat groats per day, which is achievable in the human diet. Lower cholesterol levels are 
associated with reduced risk of coronary heart disease, as the major risk factors for coronary 
heart disease are saturated fat, trans-fat intake, serum cholesterol, and obesity (Jing & Hu, 2012). 
Cholesterol reduction via a 𝛽-glucan enriched diet varies from 3% to 10%, which translates to a 
6% to 18% decrease in the risk for coronary heart disease (Martínez-Villaluenga & Peñas, 2017). 
The viscosity of oat 𝛽-glucans have also been associated with low postprandial glycemic 
response, which is a reduction in elevated blood glucose concentration after a meal, and 
insulinemic response, which is body’s use of insulin to maintain healthy blood sugar levels, via 
delayed gastric emptying, decreased carbohydrate enzymatic digestion, and reduced glucose 
diffusion and absorption (Jing & Hu, 2012; Martínez-Villaluenga & Peñas, 2017). This property 
of 𝛽-glucans have been shown to be correlated with a lower incidence of type 2 diabetes (Jing & 
Hu, 2012). 
While 𝛽-glucans account for many of the health benefits of oats, other phytochemicals 
have been associated with the antioxidant activity of oats. Some of the phytochemicals that 
contribute to the antioxidant activity of oats are tocols, flavonoids, sterols and phytic acid (Boz, 
2015; Ji, Lay, Chung, Fu, & Peterson, 2003; Peterson et al., 2005). The tocols consist of 
tocopherol and tocotrienols which exhibit vitamin E activity (Adhikari et al., 2008; Peterson et 
al., 2005). Tocols are involved in the inhibition of cholesterol biosynthesis, free radical 
scavenging, and the inhibition of proliferation of certain cancer cells. (Martínez-Villaluenga & 
Peñas, 2017; Peterson et al., 2005). Flavonoids are a large class of plant pigments that have been 
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reported to have many biological activities including free radical scavenging, vasodilatory, 
anticarcinogenic, anti-inflammatory, antibacterial, immune-simulating, antiallergic, antiviral, and 
estrogenic activity (Rice-Evans, Miller, & Paganga, 1996). The sterols are a class of lipids that 
are involved with the regulation of biological processes and the maintenance of the domain 
structure of cell membranes (Dufourc, 2008). Phytic acid is a phosphorus storage compound that 
is formed during plant maturation. Phytic acid has been reported to have strong chelation ability 
that is associated with lowered serum cholesterol and suppression of iron-mediated oxidation. 
Phytic acid’s ability to inhibit iron-catalyzed hydroxyl radical formation and lipid peroxidation 
make it a natural antioxidant (Zhou & Erdman, 1995). The antioxidative compounds that have 
been mentioned so far can all be found in oats, but can also be found in other species. The tocols 
can be found in vegetable oils, fruits, seeds, nuts and cereals (Adhikari et al., 2008); while 
flavonoids are ubiquitous in plants (Rice-Evans et al., 1996). Sterols can be found in plants as 
well as in mammals, fungi, and bacteria (Dufourc, 2008). Similar to the tocols, phytic acid is 
found in seeds and cereal grains (Zhou & Erdman, 1995). Avenanthramides (AVNs), which are 
another group of antioxidative compounds, are the focus of this research and are found 
exclusively in oats among the cereal grains (Collins, 1989).  
AVENANTHRAMIDES 
CHEMICAL STRUCTURE 
Avenanthramides are low molecular weight soluble phenolic amides, that account for the 
majority of the total soluble antioxidant phenolic compounds in oats (Collins, 1989; L. Liu, 
Zubik, Collins, Marko, & Meydani, 2004). More specifically AVNs are N-cinnamoyl derivatives 
of anthranilic acid (Emmons & Peterson, 2001). While approximately forty AVNs have been 
identified in oat extracts, three AVNs account or the majority of the total AVN content in oats 
(Collins, 1989; L. H. Dimberg, Sunnerheim, Sundberg, & Walsh, 2001; L. H. Dimberg, 
Theander, & Lingnert, 1993; M. L. Wise et al., 2008). These three main AVNs are N-(4’-
hydroxy)-(E)-cinnamoyl-5-hydroxyanthranilic acid, N-(4’-hydroxy-3’-methoxy)-(E)-cinnamoyl-
5-hydroxyanthranilic acid, and N-(3’,4’-dihydroxy)-(E)-cinnamoyl-5-hydroxyanthranilic acid (L. 
H. Dimberg et al., 2001; M. L. Wise et al., 2008). These AVNs have been given various common 
names, the most common nomenclature system will be used here, and they will be referred to as 
AVN 2p, AVN 2f, and AVN 2c, respectively. AVN 2p, AVN 2f, and AVN 2c have similar 
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chemical structures that only differ by one by one substituent, which is an atom or group of 
atoms that occupy a specific position in a molecule, and can be seen in Figure 1.1.  The 
biosynthesis of AVNs in vitro is characterized by the N-acylation of hydroxyanthraniliates with 
various hydroxycinnamoyl-CoAs which is catalyzed by the enzyme N-hydroxy-
cinnamoyltransferase (HHT) (M. L. Wise, 2011; Yang et al., 2004). In oats AVNs are 
synthesized through the condensation of substituted anthranilates and substituted cinnamoyl-
CoA thioesters, which is catalyzed by HHT (Ishihara, Ohtsu, & Iwamura, 1999; Matsukawa, 
Isobe, Ishihara, & Iwamura, 2000; Yang et al., 2004). Ishihara et al. (1999) obtained results that 
indicated the hydroxycinnamoyl units of AVNs are derived from phenylalanine via p-coumaric 
acid (Ishihara et al., 1999; Yang et al., 2004). Multiple biosynthesis pathways have been 
proposed for the hydroxycinnmamoyl units with the exception of 4-courmaroyl-CoA, which is 
formed directly from coumaric acid (Yang et al., 2004). 4-courmaroyl-CoA and 5-
hydroxyanthranilic acid are condensed to form AVN 2p (Yang et al., 2004).  AVN 2f is known 
to be synthesized through the N-acylation of 5-hydroxyanthranilic acid and feruloyl-CoA (Yang 
et al., 2004). The condensation of caffeoyl-CoA and 5-hydroxyanthranilic acid results in the 
synthesis of AVN 2c (Yang et al., 2004). The biosynthesis pathway that Yang et al. (2004) 
published for these AVNs can be seen in Figure 1.2. Largely due to the properties of AVNs, 
which will be discussed later in this paper, AVN grain concentration has been investigated. 
Avenanthramide concentration in oat groats has been found to range from 2 mg/kg to over 300 
mg/kg (Antonini et al., 2016; Boz, 2015; L. H. Dimberg et al., 1993). Avenanthramides have 
been shown to contribute not only to antioxidant activity but also to other therapeutic benefits 
including anti-inflammatory, anti-proliferative, and anti-genotoxic effects as well (Boz, 2015; 
Collins, 1989).  
ANTIOXIDANT ACTIVITY 
The antioxidant activity of AVNs has been described by numerous scientific studies. 
Peterson et al. (2002) studied the antioxidant activity of the three major AVNs using two in vitro 
analysis systems. The two in vitro systems that Peterson et al. (2002) used were an inhibition of 
β-carotene bleaching system and a reaction with the free radical 2, 2-diphenyl-1-picrylhydrazyl 
(DPPH) system. Synthesized AVNs 2p, 2f, and 2c were used instead of an oat extract to better 
ensure that the AVNs were responsible for any antioxidant activity seen.  All three of the tested 
AVNs inhibited 𝛽-carotene bleaching in a dose-dependent manner. Avenanthramide 2c was 
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found to be the most effective in the 𝛽-carotene system followed by AVN 2f and AVN 2p. In 
order to reach a reduction level of 50%, the concentration of AVN 2c needed was 2.4-fold higher 
that the synthetic antioxidant control, butylated hydroxytoluene,  while the concentration of 
AVN 2f and AVN 2p were 15-fold higher and 62-fold higher, respectively (Peterson et al., 
2002). The results seen by Peterson et al. (2002) in the DPPH system echoed the results of the 𝛽-
carotene system. Avenanthramide 2c was found to be the most effective followed by AVN 2f 
and AVN 2p. Unlike in the 𝛽-carotene system, AVN 2c and AVN 2f outperformed the control, 
Trolox.  The range of avenanthramide concentrations necessary to reach a 50% reduction in 
DPPH was narrower than the range of concentrations needed to reach 50% reduction in the 𝛽-
carotene test, though it should be noted that the 𝛽-carotene test is more sensitive than the DPPH 
test due to the solubility properties of AVNs (Peterson et al., 2002). Avenanthramides are also an 
interesting antioxidant source due to their heat stability. A study conducted by Dimerg et al. 
(1993) demonstrated, using a linoleic acid system, that 𝛼-tocopherol had an antioxidant activity 
level higher than that of AVN 2f; however, 𝛼-tocopherol was found to be sensitive to heat and 
did not withstand steam treatment while AVN 2f withstood the steam treatment (L. H. Dimberg 
et al., 1993). This is an important property of AVNs as oats are often steam treated during 
processing.  
The in vitro work done by Peterson et al. (2002) was extended by Chen et al. (2004) in an 
ex vivo study of hamster LDL cholesterol. In this study, the authors investigated the 
bioavailability of AVNs, as well as other phenolic compounds, in hamsters. BioF1B Golden 
Syrian hamsters were used in the study due to the similarity of lipoprotein metabolism between 
them and humans. Thirty hamsters were administered 250mg of oat bran slurry containing 6.8mg 
of phenolic compounds by way of stomach gavage (Chen et al., 2004). Following the 
administration of the oat bran slurry, blood samples were collected from each individual at 
designated time points. From each blood sample, plasma was isolated to be used for the 
evaluation of oat phenolic concentration. Avenanthramide 2p and AVN 2f were identified in the 
oat bran slurry at high concentrations, 2.50µmol/g and 1.97µmol/g, respectively (Chen et al., 
2004). Chen et al. (2004) found that these high concentrations of the two AVNs did not translate 
to the hamster plasma. Avenanthramide 2p and AVN 2f were identified and bioavailable in the 
hamster plasma samples, but only at the lowest concentrations, with the maximum plasma 
concentrations of AVN 2p and AVN 2f being 0.04µmol/L and 0.03µmol/L, respectively (Chen et 
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al., 2004). Chen et al. (2004) speculated that the low bioavailability of AVNs seen in the study 
may have been due to the distribution of phenolic acids and/or the biotransformation of phenolic 
acids in the hamsters. This study also tested the antioxidant activity of AVNs via Cu2+-induced 
oxidation of hamster LDL cholesterol. Hamster LDL was isolated from the plasma of the 
collected blood samples. The researchers’ results show that AVNs present in the plasma 
provided no significant resistance to Cu2+-induced LDL oxidation in the hamsters on their own 
(Chen et al., 2004). Chen et al. (2004) did note that this assay only evaluated that action of the 
oat phenolic compounds, AVNs included, that remained in association with LDL through the 
isolation process. While the antioxidant activity work done by Chen et al. (2004) is contradictory 
to the in vitro antioxidant work done by Peterson et al. (2002), Chen et al. (2004) demonstrated 
that AVNs are bioavailable in at least some mammals. The work done by Chen et al. (2004) only 
adds to the evidence, which suggest that AVNs may indeed be bioavailable to humans and 
therefore have potential to provide antioxidant activity in the human diet.  
In addition to the in vitro study performed by Peterson et al. (2002) and the ex vivo work 
done by Chen et al. (2004) , there have been several additional in vivo studies that have produced 
evidence to support the fact that AVNs provide antioxidant activity and are bioavailable to 
mammals. In a study published in 2003 by Ji et al., female Sprague-Dawley rats were fed a diet 
enriched with 0.1 g/kg of AVN 2c or a control diet before an acute bout of exercise. The study 
sought to investigate whether AVN 2c reduced reactive oxygen species generation; as well as 
investigating if AVN 2c influenced endogenous antioxidant enzyme activities (Ji et al., 2003). 
Reactive oxygen species are produced in all aerobic organisms and are cytotoxic agents that have 
the potential to cause serious oxidative stress and damage through modification of lipids, 
proteins and DNA. It is well known that reactive oxygen species production in skeletal muscle 
and myocardium is increased via physical exercise. The results from the Ji et al. study suggest 
that AVN 2c has tissue specificity in its effects. In terms of the reactive oxygen species 
concentration, AVN supplementation did not have an effect in liver tissue or in the deep portion 
of the vastus lateralis muscle, which is in the thigh. In the soleus muscle of the calf, AVN 
supplementation reduced reactive oxygen species generation; however, in heart tissue AVN 
supplementation lead to increased reactive oxygen species concentration compared to that of 
exercised rats that were fed the control diet, while kidney tissue reactive oxygen species 
concentration was unaffected by either diet or exercise. In terms of endogenous antioxidant 
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enzyme activity, Ji et al. found that AVN supplementation increased the activity of superoxide 
dismutase in liver tissue, kidney tissue, vastus lateralis muscle, and soleus muscle. In the heart, 
superoxide dismutase activity was lowest in exercised-AVN supplemented rats. Overall, Ji et al. 
provided evidence that AVN 2c can alter the intracellular oxidant-antioxidant balance and has 
the potential to function as an antioxidant against oxidative stress in a tissue specific manner (Ji 
et al., 2003). 
Chen et al. (2007) followed up their own work from 2004 with an in vivo study in 
humans that supports the findings of the Ji et al. (2003) study. In this study, six adults that had 
been following a low-flavonoid diet for one week prior were assigned to three treatment groups. 
The control treatment group received 360mL of skim milk, while the other treatment groups 
received 360mL of skim milk containing either 0.5g of an AVN-enriched mixture extracted from 
oats, or 1.0g of the AVN-enriched mixture. The AVN-enriched mixture contained AVN 2p, 
AVN 2f, and AVN 2c at concentrations of 154 µmol/g, 109 µmol/g, and 117 µmol/g, 
respectively (Chen et al., 2007). After subjects drank the test beverage (in approximately 5 
minutes) eight blood samples were collected at the following time points: 15, 30, and 45 minutes, 
and at 1, 2, 3, 5, and 10 hours. The three major AVNs were present in the plasma of the blood 
samples as early as the 15 minute time point at both dose levels of AVNs, while no AVNs were 
present in the plasma of the control group. The plasma concentration of the AVNs reached a 
peak concentration at approximately the 2 hour time point before gradually decline at later time 
points (Chen et al., 2007). The maximum plasma concentration (Cmax) of AVNs 2p ,2f, and 2c  
for subjects of the 1.0g dose treatment ranged from 0.1667 to 1.0022 µmol/g, 0.0493 to 0.1535 
µmol/g, and 0.0296 to 0.3281µmol/g, respectively (Chen et al., 2007). These AVN Cmax values 
are 231%, 627%, and 115% larger, respectively, than those of the subjects that received the 0.5g 
treatment. This finding suggests that AVN Cmax and bioavailability are dose dependent, as 
bioavailability was assessed as the area under the curve of AVN concentration to dose. These 
bioavailability results, when compared to the bioavailability results obtained by Chen et al. 
(2004), indicate that AVN absorption and metabolism are species dependent, as the 
bioavailability of AVN 2p was 18-fold greater in humans than in hamsters and the bioavailability 
of AVN 2f was 5-fold greater in humans than in hamsters (Chen et al., 2007). The researchers 
also investigated antioxidant potential of AVNs by multiple means. Chen et al. (2007) measured 
the ratio of reduced to oxidized glutathione, malondialdehyde, and glutathione peroxidase in the 
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plasma. They also tested the resistance of human LDL cholesterol via a Cu2t-induced oxidation 
assay. The plasma content of reduced glutathione increased by 21% when 1.0g of the AVN-
enriched mixture was administered increasing the reduced to oxidized glutathione ratio. The 
plasma glutathione peroxidase activity increased by 30-35% in all treatment groups. Plasma 
malondialdehyde content was unaffected by all treatments. In addition, Chen et al. (2007) found 
that AVNs alone did not provide a significant resistance to LDL oxidation induced by Cu2t; 
however, when 6µmol/g 𝛼-tocopherol, which is Vitamin E, was added prior to Cu2t-induced 
oxidation some level of LDL oxidation resistance was observed.  When the results from Chen et 
al. (2007) are complied, they suggest that AVNs are bioavailable in humans, and have the 
potential to provide antioxidant activity in vivo through increased reduced glutathione status and 
synergetic interactions with other antioxidants, such as Vitamin E (Chen et al., 2007). It is also 
important to note that these results are from acute or short-term consumption of AVNs and that 
the effects of chronic or long-term consumption of AVNs have just begun to be studied.  
ANTI-INFLAMMATORY ACTIVITY 
As stated earlier, AVNs possess anti-inflammatory properties in addition to their 
antioxidant activity. Anti-inflammatory properties have been demonstrated to help reduce the 
risk of atherosclerosis, which is the accumulation of plaque on the walls of arteries. Evidence 
supports that the inflammatory process has a pivotal role in the development of atherosclerosis, 
which can cause morbidity and mortality. Inflammatory cytokines produced by activated 
monocytes stimulate the endothelium to up-regulate the production of chemokines, cytokines, 
and adhesion molecules that mediate the build-up of immune cells to the endothelium (L. Liu et 
al., 2004). In a study conducted by Liu et al. (2004), human aortic endothelial cells (HAEC) were 
cultured and used to study the effect of AVNs in the prevention of the conditions that may lead 
to atherosclerosis. When HAEC were pretreated with an AVN enriched mixture before being 
activated with the cytokine IL-1𝛽 Liu et al. (2004) found there to be a significant reduction in the 
adherence of the human monocytic cell line U-937 to HAEC. This reduction was dose dependent 
with AVN concentrations of 4, 20, and 40 ng/mg resulting in an adherence reduction of 20, 40, 
and 45%, respectively (L. Liu et al., 2004). Liu et al. (2004) also found that AVN pretreatment 
resulted in an inhibition of adhesion molecule expression in IL-1𝛽-stimulated HAEC, and a 
significant inhibition of cytokines of unstimulated HAEC. This anti-inflammatory action of 
AVNs may therefore contribute to the heart healthy benefits of oats. 
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The work by Liu et al. (2004), which suggests that AVNs have the potential to reduce the 
risk of atherosclerosis through anti-inflammatory properties, is further supported by work done 
in 2005 by Nie et al. This 2005 study used in vitro cultures of rat embryonic aortic smooth 
muscle cells, human smooth muscle cells, and human aortic endothelial cells that were treated 
with 40, 80, or 120 µmol/L of synthetic AVN 2c to investigate the effect of AVNs on smooth 
muscle cell proliferation and nitric oxide production by endothelial cells and smooth muscle cells 
(Nie, Wise, Peterson, & Meydani, 2005). Smooth muscle cell proliferation was assessed via 
thymidine incorporation into DNA and total cell number counts. Nie et al. (2005) found that 
when quiescent human smooth muscle cells’ DNA synthesis, therefore cell proliferation, was 
stimulated with 10% fetal bovine serum, thymidine incorporation increased six- to seven-fold 
when compared to the unstimulated control. When human smooth muscle cells were treated with 
120 µmol/L of AVN 2c cell proliferation was inhibited by 50% (Nie et al., 2005). These 
thymidine incorporation results were validated through total cell number counts. When the 
human smooth muscle cells were treated for 96 hours with 40, 80, or 120 µmol/L of AVN 2c cell 
number growth was inhibited by 41, 62, and 73%, respectively (Nie et al., 2005). A 4,5 
diaminofluorescein fluorescence assay was used to measure nitric oxide production. Nitric oxide 
is an important factor in reducing the risk of atherosclerosis due to the fact that it prevents 
platelet aggregation, leukocyte adhesion, SMC proliferation, and the expression of genes that are 
involved in atherogenesis (Nie et al., 2005). AVNs proved to significantly increase nitric oxide 
production in human smooth muscle cells in a dose-dependent manner. When the AVN treatment 
was at a concentration of 120 µmol/L nitric oxide production increased 3-fold. In the human 
aortic endothelial cells, AVN 2c reached its maximum stimulatory effect at a concentration of 80 
µmol/L with a 9-fold increase in nitric oxide production (Nie et al., 2005). Nie et al. (2005) also 
found that AVN 2c caused an upregulation of endothelia NO synthase (eNOS), which is a 
catalyst of nitric oxide production, in human smooth muscle cells and in human aortic 
endothelial cells. Again this in vitro study by Nie et al. (2005) reinforces the health benefits that 
AVNs’ anti-inflammatory properties could provide if incorporated into a daily diet. 
Nie et al. followed up their own work with a study that was published in 2006. In this 
2006 study, Nie et al. sought to elucidate the potential molecular mechanism by which AVNs 
inhibit aortic smooth muscle cell proliferation. The potential molecular mechanisms that the 
researchers investigated, using rat aortic smooth muscle cells, were retinoblastoma protein (pRb) 
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phosphorylation status, signaling molecules protein p53 and cyclin-dependent kinase inhibitor 
p21cip1, and cyclin D1. Similar to their 2005 study, in vitro cultures of rat aortic smooth muscles 
cells were treated with 40, 80, or 120 µmol/L of AVN 2c. Nie et al. (2006) used flow cytometry 
with fluorescence-activated cell sorting analysis to assess cell cycle distributions in the cultures 
after a 48 hour incubation period with the AVN treatment. When the cell population was treated 
with 80 µmol/L of AVN  2c, 25.7% of the cells were found to be in the S phase of the cell cycle 
while 66.9% of the cells were in the G0/G1 phase of the cell cycle (Nie, Wise, Peterson, & 
Meydani, 2006). These results suggest that AVNs inhibit human aortic smooth muscle cells by 
arresting the progression of the cell cycle at the G1 phase (Nie et al., 2006). The researchers 
investigated pRb as a molecular mechanism because its hyperphosphorylated form is required for 
the progression of the cell cycle from G1 phase to the S phase. Nie et al. (2006) found that AVN 
2c significantly inhibited the phosphorylation of pRb without inhibiting the total level of pRb. 
The study then went even further and investigated cyclin D as a molecular mechanism, since 
cyclin D forms an active complex that is responsible for the phosphorylation of pRb (Nie et al., 
2006). The results of this experiment showed that AVN 2c suppressed the expression of cyclin 
D1 in a dose-dependent manner. The signaling molecule p53 is a tumor suppressor whose 
expression has been linked to control of cell growth in aortic smooth muscle cells; therefore, Nie 
et al. (2006) also investigated this protein. It was found that AVN 2c treatment at 40, 80, or 120 
µmol/L increased p53 protein levels by 1.8-, 3-, and 5-fold, respectively (Nie et al., 2006).  The 
effect of AVN 2c on the stability of p53 protein was investigated, as this is a common 
posttranslational regulation of the protein, by observing the half-life of p53. Avenanthramide 2c 
appeared to increase the half-life of p53, which may account of the increased expression of the 
protein (Nie et al., 2006). The final molecular mechanism investigated in this study was p21cip1, 
which has been shown to prevent the phosphorylation of pRb. Nie et al. (2006) found that AVN 
2c stimulated the expression of p21cip1 in a dose-dependent fashion. In summary Nie et al. 
(2006) showed that AVNs have the ability to arrest cell proliferation in the G1 phase of the cell 
cycle via multiple important regulatory molecules. This study reinforces that AVNs have anti-
inflammatory and anti-proliferative properties that may be impactful to human health, tumor 
suppression, and the prevention of atherosclerosis.  
The in vitro work done by Liu et al. (2004) and Nie et al. (2005, 2006) has been 
supported by further work done in in vivo systems. In 2018, a study was performed by Thomas et 
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al. where male mice, which were predisposed to atherosclerosis development, were fed either a 
low fat control diet, a high fat control diet, a high fat, low AVN diet, or a high fat, high AVN diet 
for sixteen weeks. As would be expected, the high fat control diet caused increased weight gain 
compared to the low fat control diet with AVNs at either level having no effect on weight gain. 
Avenanthramides at either the low level or the high level had an effect on total cholesterol 
concentration in plasma with a reduction of 21% when compared to the high fat control diet 
(Thomas et al., 2018).  Avenanthramides were also found to reduce the accumulation of plaque, 
more specifically, to reduce the formation of fatty lesions. The low concentration of AVNs 
reduced fatty lesion formation to a level that was comparable to that of the low fat control diet 
While, the high concentration of AVNs reduced the development of fatty lesions by 64% when 
compared to the high fat control diet and by 46.4% when compared to the low fat control diet 
(Thomas et al., 2018). Thomas et al. (2018) also provide evidence that advance fatty lesion 
formation, induced by a high fat diet, was significantly suppressed by the inclusion of AVNs at 
either the high level or low level, with no significant difference between the results of the two 
treatments. It should be noted that the concentration of AVNs in the high AVN treatment used by 
Thomas et al. (2018) far surpasses the concentration of AVNs that naturally occur in oats. 
Thomas et al. (2018) only obtained the high AVN concentration through a false-malting method, 
which most oat products are not subjected to; however, the results from Thomas et al. (2018) still 
suggest that the inclusion of AVNs in the human diet, at any level, may provide a reduced risk of 
atherosclerosis, with higher concentrations of AVNs potentially providing a significant reduction 
in risk. 
POST-HARVEST ATTRIBUTES OF AVENANTHRAMIDES 
The properties of AVNs do not only apply to human health benefits. The antioxidant 
activity of AVNs may also prevent food from going rancid as quickly (Jian et al., 2009). Oats 
contain many lipolytic enzymes, which make lipids vulnerable to oxidation (L. H. Dimberg et 
al., 2001). The current method to prevent lipid oxidation is to heat treat oats, which destroys 
natural antioxidants such as tocopherols (L. H. Dimberg et al., 2001). While AVNs seem to be 
sensitive to heat when in combination with an alkali or a neutral condition, they withstand 
regular food-processing conditions and therefore could contribute to oxidation prevention in food 
products (L. H. Dimberg et al., 2001). Avenanthramides have also been shown to be associated 
with the fresh taste of oats presumably due to its antioxidant potential (Bratt et al., 2003; Lena H. 
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Dimberg & Peterson, 2009). In addition, there is evidence that AVNs have a positive correlation 
to β-glucans, suggesting that indirect selection could be employed, since increasing one trait has 
the potential to enhance the other trait (Peterson et al., 2005).  
FACTORS THAT INFLUENCE AVENANTHRAMIDE CONCENTRATION 
Avenanthramide concentration in oats has important ramifications to human health, the 
pharmaceutical industry, and the processing industry; therefore, it is important to know if there 
are factors that affect the concentration of AVNs in oat grain. Unsurprisingly, there are several 
factors that have been shown to influence AVN concentration in the grain of oats. Numerous 
studies have identified significant genotypic differences in AVN concentration (Emmons & 
Peterson, 2001; Peterson et al., 2005). Emmons and Peterson (2001) evaluated the grain AVN 
concentrations of three genotypes; while Peterson et al. (2005) evaluated thirty-three genotypes; 
both of these studies found that genotype was highly significant. In the Emmons & Peterson 
study (2001) genotype was found to be significant at an alpha level as strict as 0.001. While 
genotypic differences contribute to the variation of AVN concentration, evidence suggests that 
environmental factors exert a large influence as well (Peterson et al., 2005). One study observed 
a 10-fold increase in the concentration of AVNs when the oats were grown in a highly-stressed 
or mildly-stressed environment (Peterson et al., 2005). An intriguing observation from this stress 
study is that there was not a significant difference in AVN concentration between the highly-
stressed and mildly stressed environments, which suggests that a mild stress may be sufficient to 
produce a strong response from the plant (Peterson et al., 2005). In particular, the presence of the 
pathogen Puccinia coronate Corda var. avenae, which is the causal agent of crown rust, in the 
environment elicits an increase in AVN concentration in both the leaves and the grain (Lena H. 
Dimberg & Peterson, 2009; M. L. Wise et al., 2008). In the Wise et al. (2008) study, crown rust 
free environments had mean AVN concentrations 10-30% lower than environments where crown 
rust was present. The Wise et al. (2008) study also found that oat genotypes with the highest 
AVN concentrations had the greatest tolerance to crown rust, as assessed in the field. This 
correlation between crown rust pressure and AVN concentration suggests that AVNs may play a 
significant role in the rejection of the crown rust pathogen and therefore in tolerance to the crown 
rust pathogen (Miyagawa, Ishihara, Nishimoto, Ueno, & Mayama, 1995). One potential 
explanation for the correlation between crown rust tolerance and grain AVN concentration is that 
AVNs play a role in the hypersensitive response (M. L. Wise et al., 2008). Phytoalexins, which 
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are substances produced by plant tissues in response to contact with a parasite, are considered to 
play an important role in disease tolerance due to their fungitoxicity (Mayama, Matsuura, Iida, & 
Tani, 1982). This fungitoxicity results in the plant hypersensitive response, which is rapid 
localized cell death around the region of infection, to microbial pathogens (M. L. Wise et al., 
2008). Supporting evidence that AVNs act as phytoalexins in the plant hypersensitive response 
to P. coronata var. avenae, is that AVN biosynthesis is induced by fungal infections or mimics 
of fungal infection (M. L. Wise et al., 2008). In addition, avenalumins, which AVNs are the open 
ring structure of, have been shown to be produced by oat in response to infection by P. coronata 
var. avenae (Mayama et al., 1982).This relationship between crown rust tolerance and AVN 
production opens up the question if other diseases impact AVN production in a similar manner, 
which is relatively unstudied.  Therefore, in this study I evaluated AVNs under Barley Yellow 
Dwarf Virus (BYDV) infection and in the absence of infection with BYDV. 
BARLEY YELLOW DWARF 
DISEASE INFORMATION 
Barley Yellow Dwarf (BYD) is a disease that affects a broad range of species in the 
Poaceae family. The causal agent of BYD was first discovered to be a virus in 1953 by Oswald 
and Houston (Zhu, Kolb, & Kaeppler, 2003). In addition to identifying the causal agent of BYD 
to be a virus, Oswald and Houston also determined that it was a positive sense, single-stranded 
RNA virus (Kaddachi, Souiden, Achouri, & Cheour, 2014). Barley Yellow Dwarf is now known 
to be caused by a group of luteoviruses, which belong to the Luteoviridae family, known as the 
Barley Yellow Dwarf Viruses (BYDVs) (Domier, 1997; Foresman et al., 2016; Gray, Smith, & 
Altman, 1993; Kaddachi et al., 2014). Two characteristics of luteoviruses are that they are 
phloem-limited and cannot be mechanically transmitted (Foresman et al., 2016; Kaddachi et al., 
2014), which holds true for the BYDVs . Barley Yellow Dwarf Viruses are obligately vectored by 
more than 25 species of aphids (Domier, 1997; Kaddachi et al., 2014). Originally, BYDVs were 
classified into five strains based on which aphid primarily vectored them (Domier, 1997). The 
BYDVs that are most efficiently vectored by Sitobion avenae are known as MAV. Those 
vectored by Rhopalosiphum maidis are designated as RMV. Viruses transmitted by 
Rhopalosiphum padi and Schizaphis graminum are known as RPV and SGV, respectively. 
Finally, BYDVs transmitted by both Rhopalosiphum padi and Sitobion avenae are known as PAV 
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(Domier, 1997). As is typical, the classification of BYDVs has evolved as knowledge and 
technology has improved. Genomic structure is now used to classify specific strains of the 
BYDVs into two genera. Virus strains PAV, MAV, and SGV are grouped into the Luteovirus 
genus; while virus strains RPV and SGV are classified into the Polerovirus genus (Foresman et 
al., 2016; Kaddachi et al., 2014). One distinction between these two genera is based on their 
replication-related protein (Foresman et al., 2016). As the main vector of BYDV in Illinois is R. 
padi transmitting PAV, this viral strain will be given precedence for the remainder of this paper.    
The PAV strain has been found to cause more severe symptoms than the RMV or the 
SGV viral strains (Gray et al., 1993). The PAV strain is also the best studied of the BYDVs as it 
is the most widespread (Miller and  & Rasochová, 1997).  All BYDVs are transmitted through 
persistent feeding by the aphid vector on the host plant (Fitzgerald & Stoner, 1966).  These 
viruses also display a circulative transmission, meaning in this case that the viruses must pass 
three transmission barriers within the aphid in order to complete the transmission process and be 
virulent (Domier, 1997; Miller and  & Rasochová, 1997). In addition to being circulative, BYDVs 
are also non-propagative, meaning that no viral multiplication takes place within the vector 
(Kaddachi et al., 2014). In part due to the non-propagative nature of the BYDVs, reduced virus 
titer accumulation in host plants has been found to be correlated with reduced aphid transmission 
efficiency and reduced virus spread (Gray et al., 1993; Skaria, Lister, Foster, & Shaner, 1985). 
The importance of this correlation with be discussed further in terms of its impact on control and 
tolerance later in this paper.   
Barley Yellow Dwarf Viruses can have a range of characteristic symptoms in oats that 
include stunted growth, yellow to red leaf discoloration, blasting of florets, inhibition of root 
formation, and a reduction in tillering, and delayed heading (Jin, Domier, Kolb, & Brown, 1998; 
Miller and  & Rasochová, 1997; Zhu et al., 2003). Some of these symptoms are caused by the 
virus multiplying within the phloem. Infected phloem cells are destroyed and assimilate 
translocation is reduced as the virus multiplies within the phloem. Reduced assimilate 
translocation leads to an accumulation of carbohydrates that interfere with plant physiological 
processes, such as photosynthesis (Kaddachi et al., 2014). The symptoms of BYDVs are most 
severe in oats, with symptoms in wheat and barley being less pronounced. Symptom severity can 
also vary due to virus strain, oat cultivar, the developmental stage of the host plant at infection, 
and environmental conditions (Barbosa-neto et al., 2000). In a study conducted in wheat, BYD 
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severity was shown to increase at cooler temperatures, and when light intensity was relatively 
high and coupled with long photoperiods (Fitzgerald & Stoner, 1966). Another study conducted 
by Gray et al. published in 1993, showed the effect oat cultivar can have on BYD symptom 
expression. The authors inoculated three oat cultivars, Coast Black (susceptible), Ogle 
(resistant), and IL86-5262 (highly resistant), with the PAV isolate of the BYDVs among other 
isolates. Coast Black displayed classic BYD symptoms irrespective of the BYDV isolate used. 
Ogle exhibited less severe symptoms than Coast Black independent of the isolate used for 
inoculation. Inoculation of Ogle with the PAV isolate still caused leaf discoloration; however, 
maturity tended to attenuate symptom expression (Gray et al., 1993). The Illinois breeding line, 
IL86-5262, was found to be asymptomatic in all cases. Symptomatology of BYDVs and BYD 
itself are of importance because they often lead to reduced yield and grain quality of oats and 
cereal crops in general.  
AGRONOMIC IMPACT ON OATS 
It is globally recognized that BYD is one of the most damaging viral diseases that affects 
cereal crops (D’Acry & Burnett, 1995). Barley Yellow Dwarf is found in nearly every region of 
the world where grains are grown, resulting in substantial economic losses of cereal crops around 
the world (Domier, 1997; Gray et al., 1993). Barley Yellow Dwarf accounts for annual yield 
losses of up to 30% in cereal grains in the United States alone (Barbosa-neto et al., 2000), while 
some areas report yield losses of up to 86% (Kaddachi et al., 2014). One study reported that each 
1% increase in BYD incidence can account for economic losses of 13 to 25 kg/ha in spring sown 
wheat (McKirdy, Jones, & Nutter Jr, 2002). Another study conducted by Perry et al. (2000) 
reported estimated yield losses in soft red winter wheat of 27 and 45 kg/ha for each 1% increase 
in BYDV-PAV incidence, which is considerably higher than the yield reductions reported by 
McKirdy et al. (2002). One explanation for the differences in yield losses seen between these 
two studies is the differences in planting dates, while another factor may be the differences 
among cultivar in BYDV tolerance. As BYD is known to stunt the growth of the plant host, fall 
infection of BYDV may make the crop more susceptible to winter injury. However, Perry et al. 
(2000) reported that early spring infection of winter wheat by BYDV resulted in higher disease 
incidence and greater yield reduction than fall infection of winter wheat by BYDV. In addition to 
the data reported by McKirdy et al. (2002) on wheat, the study also reported data on oats. The 
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McKirdy et al. (2002) study reported yield reductions for each 1% increase in BYDV incidence, 
of 44 to 55 kg/ha in oats (McKirdy et al., 2002).  
These studies emphasize the importance of understanding the complexity of disease 
epidemiology and all the aspects that play a role in it, which can include host cultivar, pathogen 
isolate, time of infection, and environment. In an experiment where an oat cultivar was 
inoculated with a PAV isolate of BYDV in a controlled non-field environment, a yield reduction 
of 66%  was observed in oats when compared to healthy plants (Potter, 1982). The results of this 
experiment have the potential to be very different if one or any combination of the variables were 
to be changed, such as the oat cultivar, pathogen isolate, or growing environment. In this study, 
the reduction in oat yield was primarily due to a decrease in the number of grains per head 
(Potter, 1982). While these kind of correlations can be rather easily drawn between visual BYDV 
symptoms and yield reductions in oats, such correlations are harder to draw in wheat since wheat 
varieties may be asymptomatic for BYDV,  but the virus may still cause yield reductions (Perry et 
al., 2000). The impact of diseases on agronomic traits can be difficult to elucidate due to the fact 
that disease epidemiology and agronomic traits are both often a complex combination of factors. 
IMPACT ON NUTRITIONAL AND QUALITY TRAITS  
As stated earlier the ideal oat grain composition or oat grain quality for human nutrition 
is a high protein concentration, a high soluble dietary fiber concentration, and a low oil 
concentration. In a study done by Potter (1982) the infection of an oat cultivar by BYDV resulted 
in a significant increase in crude protein in the grain due to reduced oil and starch accumulation. 
While increased protein concentration may be a desirable trait, the overall loss of yield far 
outweighs any benefit. In addition to disease, many other factors can influence grain quality in 
oats. One study showed that genotype and environment could be factors in the determination of 
oil concentration in oat grain (Doehlert, McMullen, & Hammond, 2001). The same study 
reported the stimulation of oil accumulation in the grain by cooler growing environments; as well 
as, a negative correlation between protein concentration and oil concentration for different oat 
genotypes (Doehlert et al., 2001). While quantifying the concentrations of protein, soluble 
dietary fiber, and oil in the oat grain may be the most precise measurement of oat quality it is 
time-consuming and labor intensive to do these analyses. As a result, other characteristics that 
describe oat quality are commonly used.  
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CONTROL AND TOLERANCE 
Since BYD can have a detrimental impact on oat yield and can influence grain quality, 
disease management is a priority. Several management strategies for BYD exist. One such 
strategy is varying the planting date in an attempt to avoid times when the disease vectors are 
most active. As this is difficult to do and often not effective planting date as a method of control 
for BYD is seldom used. Aphicidal seed treatments are also available and can be effective for 
controlling BYD. These aphicidal treatments typically have effectiveness periods of 6-8 weeks 
post sowing. The effectiveness period of these treatments make them best suited to the more 
northern growing environments of the United States where temperatures drop low enough to 
prevent aphid movement before the effectiveness period has elapsed (Perry et al., 2000). In 
addition to the management strategies already discussed, there are two other more commonly 
used management strategies for BYDVs which include control of aphid vector populations and 
use of tolerant or resistant oat cultivars. The control of aphid populations through insecticides is 
rarely used outside of intensive agricultural systems, because it often takes numerous, well-timed 
applications of the insecticide to achieve effective control of BYDVs and economic benefits are 
seldom sufficient to justify the use of insecticides.  
Since insecticidal control is often not a feasible management strategy, a significant 
amount of research has been done to identify sources of natural genetic tolerance or resistance in 
oat to BYD. Genetic resistance is sometimes distinguished from genetic tolerance, though the 
terms are often used interchangeably. Resistance is defined as the plant’s ability to not be 
affected by the pathogen, while tolerance is defined as the plant’s ability to endure the pathogen. 
Resistance, which is often referred to as virus resistance, is specifically defined for BYDVs as a 
reduction of virus titer in the infected plant (Cooper & Jones, 1983). Numerous studies have 
found that oat cultivars that are resistant to BYD accumulate less viral antigen than cultivars that 
are considered susceptible to the disease (Gray et al., 1993; Jedlinski, Rochow, & Brown, 1977; 
Skaria et al., 1985). Reduced virus titer accumulation also attenuates viral spread as resistant 
cultivars are often inadequate sources of the virus, which effects the ability of aphids to acquire a 
sufficient amount of the virus for transmission (Gray et al., 1993; Skaria et al., 1985). In many 
cases it is undetermined if fewer aphids are acquiring the virus or if all aphids are acquiring less 
virus, though the latter is the more supported theory (Gray et al., 1993).  
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 Tolerance, which is often referred to as field resistance, in terms of BYDVs is the 
reduction of symptoms and yield losses independent of virus titer (Cooper & Jones, 1983; 
Foresman et al., 2016; Kaddachi et al., 2014). As numerous studies do not quantify virus titer, 
tolerance will be primarily referred to throughout this paper unless stated otherwise. Many 
studies have tried and failed to find sources for BYDV tolerance that is simply inherited (Jin et 
al., 1998; McKenzie, Burnett, Gill, Comeau, & Brown, 1985). Instead, BYDV tolerance appears 
to be inherited in a quantitative manner (Jin et al., 1998; Zhu et al., 2003). The high levels of 
BYDV tolerance that have been identified in oats have been shown to be conditioned by 2-4 
interacting genes (Jin et al., 1998; McKenzie et al., 1985; Zhu et al., 2003). Studies have detected 
anywhere from 3-21 quantitative trait loci (QTL) that are associated with BYDV tolerance 
(Barbosa-neto et al., 2000; Jin et al., 1998; Zhu et al., 2003). In a study performed by Foresman 
et al. (2016), 428 oat cultivars were used as an association mapping population from which 6 
single nucleotide polymorphisms (SNP) were identified as significant for BYD tolerance. Four 
of the SNPs were located on chromosome 3C, while the other two SNPs were located on 
chromosome 18D. One of the SNPs on chromosome 3C was found to account of 17% of the 
variance seen in the study (Foresman et al., 2016). When the six marker sequences were blasted 
this SNP was found to have a 65% agreement with a mosaic virus helicase domain binding 
protein in wheat. The SNP of the greatest significance on chromosome 18D accounted for 6% of 
the variation in the study and was found to agree with a previously identified QTL. Overall this 
study found that BYD tolerance was highly heritable with a broad-sense heritability of 0.91 
(Foresman et al., 2016). The results of the Foresman et al. (2016) study are of particular interest, 
because a subset of this association mapping population was used to conduct the research that 
will be discussed in the chapter titled Quantification of Avenanthramides in Multiple 
Environments in this paper. In addition to the existing genetic diversity for BYD tolerance in A. 
sativa, other potential sources have been suggested. These potential sources for additional  BYDV 
tolerance genes that could be incorporated into A. sativa include A. sterilis, A. fatua, and A. 
occidentalis (Comeau, 1984). While there are other methods of control for BYD, breeding of 
tolerant and resistant cultivars is the most cost-effective and sustainable management strategy for 
controlling BYD (Domier, 1997).  
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CHAPTER 2: QUANTIFICATION OF AVENANTHRAMIDES IN MULTIPLE 
ENVIRONMENTS 
INTRODUCTION  
Spring oats (Avena sativa L.) provide a good source of carbohydrates, fiber, lipids, and 
balanced proteins, as well as several vitamins making oat an ideal addition to the human diet. 
The U.S. Food and Drug Administration has approved health claims that are associated with 𝛽-
glucans, which are the main source of soluble dietary fiber in oats (Martínez-Villaluenga & 
Peñas, 2017); however, 𝛽-glucans are not the only phytonutrient of interest in oats. 
Avenanthramides (AVN) are a group of phytonutrients that are unique to oats among cereal 
grains, and are believed to account for a large portion of the antioxidant properties of the species 
(Chen et al., 2007; Peterson et al., 2002). Approximately 40 AVNs have been identified in spring 
oats, but there are three AVNs that account for the majority of the grain AVN concentration. 
These avenanthramides are AVN 2c, AVN 2p, and AVN 2f (M. L. Wise et al., 2008). While 
there has been research on the phenotypic expression of AVNs, this work has been limited in 
geographical region, study size, and the number of factors considered. There has been a 
significant amount of research into the relationship of grain AVN concentration and the fungal 
disease crown rust (caused by Puccinia coronata Corda var. avenae), which has resulted in the 
discovery of a correlation between crown rust tolerance and increased grain AVN concentration 
(Peterson et al., 2005; M. L. Wise et al., 2008). One objective in this study was to determine if a 
similar relationship exists between grain AVN concentration and Barley Yellow Dwarf Virus 
(BYDV) tolerance as barley yellow dwarf (BYD) is an important disease in oats that causes 
stress, which has been shown to influence AVN concentrations (Peterson et al., 2005). The other 
objectives in this study were to assess the overall diversity of the small grains oat breeding 
program at UIUC, the genotype-by-environment effect on AVN concentration, and the 
heritability of grain AVN concentration in Illinois. 
MATERIALS AND METHODS 
PLANT MATERIALS 
All studies were conducted using 100 oat cultivars that have a range of tolerance to 
BYDV. Ninety-six of the oat cultivars in this population are from a pre-existing population 
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(Foresman, 2014, Foresman, 2016, Foresman et al., 2016). An additional four cultivars were 
added to the population as BYDV checks to help set the disease severity rating scale. The 
population is of diverse background and was used to map quantitative trait loci (QTL) for BYD 
tolerance, as such the genotypic information of all lines is available. Of those 100 cultivars, 79 
are breeding lines that were developed by the small grains breeding group at UIUC. Six of those 
79 Illinois breeding lines are still being evaluated in the small grains oat breeding program at 
UIUC. Forty-three of the cultivars were used as parents for crosses in 2017 or 2018, with 14 
cultivars being used as parents in both years. Only a select few of the cultivars in this study have 
been previously phenotyped for AVN concentration. One of the genotypes in this population that 
has been phenotyped for AVN concentrations is IL09-6937, whose significance is discussed in 
the Introduction to Research and Objectives in the Literature Review of this paper. A sister line 
of IL09-6937 (IL09-6934) and the parents of IL09-6937 (IL04-4410 and Corral) are included in 
the population as well.  
BARLEY YELLOW DWARF VIRUS STUDY 
The BYDV study was conducted in one environment located in Urbana, IL on the Crop 
Sciences Research and Education Center (CSREC) of UIUC. The study was planted and data 
were collected in the summers of 2017 and 2018. This environment had a combination of Elburn 
silt loam and Drummer silty clay soil types in 2017 (40.084086, -88.231678). In the 2018 
growing season this environment had a soil type of Elburn silt loam (40.084112, -88.228624). 
The 100 oat cultivars were planted in a randomized complete block design (RCBD) containing 
three replications with each block being comprised of one complete replication. This 
environment was planted in hill plots with 15 seeds per hill, with an individual hill representing 
one of the 100 cultivars. The 15 seed hills were spaced one foot apart and the rows of 15 seed 
hills were spaced two feet apart. This 300 hill experiment was hand planted using a jab planter. 
This experiment was planted on March 14th (Julian day 83) in the 2017 season, and on March 
22nd (Julian day 81) in the 2018 season. Once the hills had reached Feekes growth stage 1 or 2, 
which are characterized by emergence and the beginning of tillering (K. Wise, Johnson, Botany, 
& Pathology, n.d.), the hills were inoculated with aphids that were harboring the PAV serotype 
of BYDV. The aphid species that was used as a vector for the PAV serotype was the bird-cherry 
oat aphid (Rhopalosiphum padi). These viruliferous aphids are reared on barley plants in the 
greenhouse. Viruliferous aphids are produced on plants year round to maintain the disease. The 
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aphid population must be transferred to healthy barley plants approximately every 2 weeks to 
prevent colony collapse. A month prior to field inoculation the aphid population was increased to 
reach a size adequate for inoculation. For inoculation aphids are collected from the barley plants 
and mixed 50:50 volume to volume with cornmeal. The aphids were applied using a dispenser 
that distributes an equal amount of a cornmeal-aphid mixture to each hill with approximately 20 
to 30 aphids being placed on each hill. The addition of cornmeal to the aphids was necessary to 
prevent the honeydew, which is produced by the aphids, from causing the aphids to clump 
together. Inoculation occurred on April 18th in 2017 (Julian day 108), and on April 24th (Julian 
day 114) in 2018. Approximately five to seven days after inoculation the experiment was 
sprayed with Warrior® pesticide (Lambda-cyhalothrin) to kill the aphids. In 2017 the hills were 
sprayed on April 24th (Julian day 114), and in 2018 on May 1st (Julian day 121). Once the hills 
had reached Feekes growth stage 10, each hill was phenotypically evaluated for sensitivity to 
BYDV. A 0 to 9 rating system based on leaf chlorosis, stunting, and blasting of panicles was used 
to assign tolerance ratings to each hill. In this rating system a 0 represents a plant with no leaf 
discoloration, no stunting, and no blasting, while a 9 represents a severely stunted individual that 
fails to head. The cultivars were rated on June 12th (Julian day 163) in both the 2017 and 2018 
seasons. The experiment was sprayed with the fungicide Tilt® (Propiconazole), in an effort to 
prevent other diseases from infecting the study and causing pathogen interactions. Fungicide 
application was only necessary in the 2017 growing season and was applied on June 14th (Julian 
day 165), at a rate of 0.33 fluid ounce of Tilt® per gallon of water.  The experiment was 
monitored for natural crown rust infection. If natural crown rust infection had occurred then 
crown rust tolerance ratings would have been taken; however, no crown rust was present in the 
environment in neither 2017 nor 2018. This experiment was harvested on July 8th (Julian day 
189) in 2017, and on July 12th (Julian day 193) in 2018.  
DIVERSITY STUDY 
The diversity study included three environments grown in the summers of 2017 and 
2018. One environment in this study was Urbana, Illinois environment that was used for the 
BYDV study. The second environment was planted at the UIUC research station located in 
Monmouth, Illinois. This Monmouth environment had a Muscatune silt loam soil in both 
growing seasons. This northern Illinois environment was laid out in with the same design as the 
BYDV nursery, with the exception that this environment was under natural field conditions. In 
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2017, this environment was planted on March 21st (Julian day 80) (40.930201, -90.720536). This 
northern Illinois environment was planted on March 22nd (Julian day 81) in 2018 (40.936115, -
90.721584). This environment was not inoculated with BYDV or any other pathogen. There is 
typically a strong natural crown rust pressure at this location and the experiment was monitored 
for natural crown rust infection; however, natural crown rust infection did not occur in either the 
2017 growing season or the 2018 growing season. Hills at this location were harvested on July 
17th (Julian day 198) in 2017 and on July 6th (Julian day 187) in 2018.  
The third environment was planted in Urbana, Illinois on the CSREC of UIUC in the 
summers of 2017 and 2018. This third environment was under natural field conditions. The soil 
type of this environment in 2017 was Elburn silt loam (40.085125, -88.230137). In 2018 this 
environment had a combination of Elburn silt loam and Drummer silty clay soil types 
(40.085108, -88.228688). This environment set up in the same RCBD design as the other 
environments in the study. The cultivars were planted in meter long single rows in this Urbana, 
IL natural field conditions environment. It should be noted that in 2017 only one replication of 
this treatment was planted due to seed limitations. This third environment was planted on March 
23rd (Julian day 82) in 2017 and on March 22nd (Julian day 81) in 2018. Like the other Urbana, 
Illinois environment, this environment was sprayed with the fungicide Tilt® in 2017, in an effort 
to maintain a disease-free environment. This experiment was monitored for any natural infection 
of disease including, BYDV and crown rust. There was no occurrence of natural crown rust or 
natural BYDV infection in 2017 or 2018 in this environment. In 2017, this location was harvested 
on July 8th (Julian day 189) and on July 12th (Julian day 193) in 2018.  
AVENANTHRAMIDE EXTRACTION AND QUANTIFICATION 
At the end of each growing season, all replications at all environments were harvested. 
The harvested grain was threshed and stored until grain analysis could be performed to quantify 
the grain AVN concentration. The grain analysis was performed using High-Performance Liquid 
Chromatography (HPLC). The following AVN extraction and HPLC analysis protocols have 
been compiled and adapted from the protocols published by Wise et al., 2008, Wise, 2011, 
Emmons & Peterson, 2001, and Collins, 1989. Two field replications from all three 
environments were selected to be analyzed and quantified. Two replications were analyzed and 
quantified due to resource and time limitations. The grain was prepared for the HPLC analysis by 
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separating the hulls of the oats from the groats using an impact dehulling machine or by hand-
dehulling. The hulls of the oats were discarded, and the groats were saved. The saved groats 
were finely ground into a powder using coffee grinder and then passed through a 0.5-millimeter 
screen. A 0.15 gram aliquot of the ground groat samples was extracted in triplicate using 1.5 
milliliters of 80% ethanol, made with 10 millimolar monosodium phosphate (NaH2PO4) buffer 
with a pH of 2.8. The groat samples with extraction buffer were placed in a shaker at 50° Celsius 
for twenty minutes, and then centrifuged for seven minutes at 3000g. Following centrifugation, 
the supernatants were removed and placed in 15-milliliter tubes. The supernatants obtained from 
the second and third rounds of extractions for each sample were added to the supernatant of the 
first extraction of the corresponding sample. Three repeated extractions were performed to assure 
optimum recovery of AVNs (Pridal, Böttger, & Ross, 2018). The pooled supernatants from each 
sample were rotary evaporated under a vacuum in a speedvac until dry and then resuspended in 
600 microliters of methanol. The resuspended samples were passed through a 0.2-micrometer 
polytetrafluoroethylene (PTFE) syringe filter to prevent debris from entering the HPLC. The 
analysis was conducted using a Agilent 1100 Series HPLC® and  a Poroshell C18 column® (4.6 
x 100 millimeter 2.7 micrometers). The HPLC was equipped with a diode array 
spectrophotometer detector with detection set at 340 nanometers. The mobile phase used in the 
HPLC analysis was composed of buffer A, which was water with 5% acetonitrile and 0.1% 
formic acid, and buffer B, which was acetonitrile with 0.1% formic acid. The linear gradient was 
15 to 26% buffer B over 35 minutes with a flow rate of 1.0 milliliter per minute. All AVN 
analysis conducted using HPLC were made using a 10 microliter injection of the prepared 
samples at room temperature. The reproducibility of the extraction protocol was tested by 
extracting three subsamples of Illinois breeding line IL09-6937 and then running the three 
subsamples through the HPLC. This reproducibility test resulted in standard deviations of 2.18, 
6.57, and 29.36 for AVN 2c, AVN 2p, and AVN 2f, respectively. Peak identity was confirmed 
using electrospray ionization liquid chromatography mass spectrometry (ESI LCMS) at the 
School of Chemical Sciences Mass Spectrometry Lab on the UIUC campus. Results for the ESI 
LCMS were compared to the published literature and pure standards. 
The peak areas from the HPLC chromatograms were compared to an external standard 
curve of purified AVNs. A known concentration of a pure AVN standard was run through the 
HPLC with the above described procedure. This was repeated with an increased concentration 
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each time until a concentration that was above a level that would reasonably be seen in a sample 
was obtained. The concentrations of pure AVN standards used to construct the external standard 
curve were 1.95, 3.91, 7.81, 15.63, 31.25, 62.50, 125, 250, and 500 𝜇𝑔/𝑚𝐿 with 2% formic acid 
being used in dilution. The area under the peak for each of these runs was then plotted against 
the concentration of each run to determine the slope of the line. The concentration of an AVN in 
a sample could then be quantified by dividing the area under the peak by the slope of that AVN 
standard plot. HPLC output from samples can be seen in Figures 2.1 – 2.4. This process was 
used for all three of the AVNs investigated in this study.  
STATISTICAL ANALYSIS  
BARLEY YELLOW DWARF VIRUS STUDY 
To analyze the relationship between BYDV tolerance and grain AVN concentration the 
following factorial RCBD model was used.  
𝑌𝑖𝑗𝑘 = 𝜇 + 𝑌𝑖 + 𝑅(𝑖)𝑗 + 𝐺𝑘 + 𝑌𝐺𝑖𝑘 + 𝜀(𝑖)𝑗𝑘 
where 𝑌𝑖𝑗𝑘 is the grain AVN concentration recorded for the i
th year, the jth replication nested in 
the ith year, and the kth genotype (i = 1, 2; j = 1, 2; k = 1, 2,…,100); 𝜇 is the grand population 
mean; 𝑌𝑖 is the random effect of the i
th year, NID(0, 𝜎𝑌
2); 𝑅(𝑖)𝑗 is the random effect of the j
th 
replication nested in the ith year, NID(0, 𝜎𝑅
2); 𝐺𝑘 is the random effect of the k
th genotype, 
NID(0, 𝜎𝐺
2); 𝑌𝐺𝑖𝑘 is the random effect of the year-genotype interaction, NID(0, 𝜎𝑌𝐺
2 ); and 𝜀𝑖𝑗𝑘 is 
the random error term, NID(0, 𝜎𝑒
2). Only the data collected from the BYDV inoculated 
environment were used in this analysis. The above model was run one time for AVN 2c, AVN 
2p, and AVN 2f concentration, as well as, for the total AVN concentration. The model was also 
run another time with everything held the same except 𝑌𝑖𝑗𝑘, which became the BYDV tolerance 
rating recorded for the ith year, the jth replication nested in the ith year, and the kth genotype (i = 1, 
2; j = 1, 2; k = 1, 2,…,100).  
All statistical analyses were conducted in SAS 9.4 (SAS Institute, 2017) using the PROC 
MIXED, UNIVARIATE, GLM, GPLOT, and CORR commands. The ANOVA described above 
was conducted in MIXED using the REML method. Residuals were output from the MIXED 
procedure and analyzed in UNIVARIATE to test the assumption of normally distributed errors. 
A Brown-Forsythe modification of the Levene test was used in GLM to test the assumption of 
29 
 
homoscedasticity. A natural log transformation was applied to the response variables for all traits 
evaluated in order to meet the above-mentioned assumption of homoscedasticity. The best linear 
unbiased predictions (BLUPs) for genotypes were calculated for each of the response variables 
using the following equation:  
𝐵𝐿𝑈𝑃..𝑘 = ?̅?… + 𝐺𝑘 
where ?̅?… is the overall population mean, and 𝐺𝑘 is the random effect of a given genotype. 
BLUPs were used instead of means or least square means (lsmeans) because BLUPs account for 
random effects by introducing an adjustment called a shrinkage effect. The solutions to the 
random effects were obtained through MIXED. These BLUPs were then run through CORR to 
analyze the correlation between the BLUPs and therefore the relationship between BYDV 
tolerance and grain AVN concentration.   
DIVERSITY STUDY 
The overall diversity, genotype-by-environment effect, and heritability of grain AVN 
concentration were analyzed using the following RCBD model. 
𝑌𝑖𝑗𝑘𝑙 = 𝜇 + 𝑌𝑖 + 𝐸𝑗 + 𝑅𝑘(𝑖𝑗) + 𝑌𝐸𝑖𝑗 + 𝐺𝑙 + 𝑌𝐺𝑖𝑙 + 𝐸𝐺𝑗𝑙 + 𝑌𝐸𝐺𝑖𝑗𝑙 + 𝜀𝑖𝑗𝑘𝑙 
where 𝑌𝑖𝑗𝑘𝑙 is the grain AVN concentration recorded for the i
th year, the jth environment, the kth 
replication nested in the ith year and jth environment , and the lth genotype (i = 1, 2; j = 1, 2, 3; k = 
1, 2; l=1,2,3,…,100); 𝜇 is the grand population mean; 𝑌𝑖 is the random effect of the i
th year, 
NID(0, 𝜎𝑌
2); 𝐸𝑗 is the random effect of the j
th environment, NID(0, 𝜎𝐸
2); 𝑅𝑘(𝑖𝑗) is the random 
effect of the kth replication nested in the ith year and jth environment, NID(0, 𝜎𝑅
2); 𝑌𝐸𝑖𝑗 is the 
random effect of the year-environment interaction, NID(0, 𝜎𝑌𝐸
2 );  𝐺𝑙 is the random effect of the 
lth genotype, NID(0, 𝜎𝐺
2); 𝑌𝐺𝑖𝑙 is the random effect of the year-genotype interaction, 
NID(0, 𝜎𝑌𝐺
2 );   𝐸𝐺𝑗𝑙  is the random effect of the environment-genotype interaction, NID(0, 𝜎𝐸𝐺
2 ); 
𝑌𝐸𝐺𝑖𝑗𝑙 is the random effect of the year-environment-genotype interaction, NID(0, 𝜎𝑌𝐸𝐺
2 );  and 
𝜀𝑖𝑗𝑘𝑙 is the random error term, NID(0, 𝜎𝑒
2). Data from all three environments were used in this 
analysis. The above model was run one time for AVN 2c, AVN 2p, and AVN 2f, as well as, once 
for the total of the three AVN concentrations.  
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All statistical analyses were conducted in SAS 9.4 (SAS Institute, 2017) using the PROC 
MIXED, UNIVARIATE, GLM, GPLOT, and CORR commands. The ANOVA described above 
was conducted in MIXED using the REML method since there is one replication of missing data 
due to the seed limitations mentioned earlier. Residuals were output from the MIXED procedure 
and analyzed in UNIVARIATE to test the assumption of normally distributed errors. The 
assumption of homoscedasticity was assessed in GLM using the residuals. A natural log 
transformation was applied to the AVN response variables in order to meet the above-mentioned 
assumption of homoscedasticity. The BLUPs for the three-way interaction among year, 
environment, and genotype were calculated as follows for all response variables:  
𝐵𝐿𝑈𝑃𝑌𝐸𝐺𝑖𝑗.𝑙 = ?̅?… + 𝑌𝑖 + 𝐸𝑗 + 𝐺𝑙 + 𝑌𝐸𝑖𝑗.. + 𝑌𝐺𝑖..𝑙 + 𝐸𝐺.𝑖.𝑙 + 𝑌𝐸𝐺𝑖𝑗.𝑙 
where ?̅?… is the overall population mean, 𝑌𝑖 is the random effect of a given year,  𝐸𝑗 is the 
random effect of a given environment, 𝐺𝑙 is the random effect of a given genotype,  𝑌𝐸𝑖𝑗.. is the 
random effect of a given year-environment combination, 𝑌𝐺𝑖..𝑙 is the random effect of a given 
year-genotype combination, 𝐸𝐺𝑖..𝑙 is the random effect of a given environment-genotype 
combination, and 𝑌𝐸𝐺𝑖𝑗.𝑙 is the random effect of a given year-environment-genotype 
combination. The solutions to the random effects were obtained from MIXED. As in the BYDV 
study, BLUPs were used instead of means or lsmeans because BLUPs account for random 
effects by introducing an adjustment called a shrinkage effect. These three-way interaction 
BLUPs were then plotted by genotype and log AVN concentration using GPLOT to break apart 
the year-environment-genotype interaction in 2017 and 2018.  
All two-way interaction BLUPs were calculated as well. The BLUPs for the two-way 
interaction between year and environment were calculated as follows: 
𝐵𝐿𝑈𝑃𝑌𝐸𝑖𝑗.. = ?̅?… + 𝑌𝑖 + 𝐸𝑗 + 𝑌𝐸𝑖𝑗.. 
where ?̅?… is the overall population mean, 𝑌𝑖 is the random effect of a given year,  𝐸𝑗 is the 
random effect of a given environment, and  𝑌𝐸𝑖𝑗.. is the random effect of a given year-
environment combination. The solutions of the random effects used in the above calculation 
were obtained from MIXED. Again, profile plots of the interaction between year and 
environment were constructed by plotting the year-environment BLUPs by genotype and log 
AVN concentration. These profile plots were used to further investigate the interaction.  
31 
 
 The BLUPs for the two-way interaction between year and genotype were calculated as 
follows: 
𝐵𝐿𝑈𝑃𝑌𝐺𝑖..𝑙 = ?̅?… + 𝑌𝑖 + 𝐺𝑙 + 𝑌𝐺𝑖..𝑙 
where ?̅?… is the overall population mean, 𝑌𝑖 is the random effect of a given year, 𝐺𝑙 is the random 
effect of a given genotype, and 𝑌𝐺𝑖..𝑙 is the random effect of a given year-genotype combination. 
The solutions of the random effects used in the above calculation were obtained from MIXED. 
Profile plots of the interaction between year and genotype were constructed in the same fashion 
as the year-environment interaction profile plots, and used to investigate the year-genotype 
interaction. These BLUPs were also used to run correlations between all AVNs in all years using 
CORR in SAS 9.4 (SAS Institute, 2017).  
The BLUPs for the two-way interaction between environment and genotype were 
calculated as follows: 
𝐵𝐿𝑈𝑃𝐸𝐺.𝑗.𝑙 = ?̅?… + 𝐸𝑗 + 𝐺𝑙 + 𝐸𝐺.𝑖.𝑙 
where ?̅?… is the overall population mean, 𝐸𝑗 is the random effect of a given environment, 𝐺𝑙 is the 
random effect of a given genotype, and 𝐸𝐺𝑖..𝑙 is the random effect of a given environment-
genotype combination. The solutions of the random effects from the above calculation were 
obtained through MIXED. Once again, profile plots of this interaction were constructed in the 
same manner as described for the other two-way interactions, and used in order to examine the 
environment-genotype interaction.  
The BLUPs for genotypes were calculated for each of the response variables using the 
following equation:  
𝐵𝐿𝑈𝑃…. = ?̅?…. + 𝐺𝑙 
where ?̅?… is the overall population mean, and 𝐺𝑙 is the random effect of a given genotype. 
BLUPs were used instead of means or least square means (lsmeans) because BLUPs account for 
random effects by introducing an adjustment called a shrinkage effect. The solutions to the 
random effects were obtained through MIXED. These BLUPs were then run through CORR to 
analyze the correlation between all AVNs based on combined data from 2017 and 2018.  
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The narrow-sense heritability of the grain avenanthramide concentrations was estimated 
as follows: 
ℎ2 =
𝜎𝐺
2
𝜎?̅?…𝑙
2  
where 𝜎𝐺
2 is the overall genotypic variance, and 𝜎?̅?…𝑙
2  is the variance of a given genotype. There 
are two different methods used to calculate the denominator of the above equation. The first 
method calculates 𝜎?̅?…𝑙
2  as follows: 
𝜎?̅?…𝑙
2 = 𝜎𝐺
2 +
𝜎𝑌𝐺
2
𝑖
+
𝜎𝐸𝐺
2
𝑗
+
𝜎𝑌𝐸𝐺
2
𝑖 ∗ 𝑗
+
𝜎𝑒
2
𝑖 ∗ 𝑗 ∗ 𝑘
 
where 𝜎𝐺
2 is the overall genotypic variance, 𝜎𝑌𝐺
2  is the overall variance of the year-genotype 
combination, 𝜎𝐸𝐺
2  is the overall variance of the environment-genotype combination, 𝜎𝑌𝐸𝐺
2  is the 
overall variance of the year-environment-genotype combination, i is the number of years, j is the 
number of environments, and k is the number of replications. The above method of estimating 
narrow-sense heritability is referred to as the plant breeding (Bernardo, 2010; Dudley & Moll, 
1969). This plant breeding method only takes into account the variance components that involve 
genotype and the error variance.  
The second method of estimating the denominator of the narrow-sense heritability 
equation is referred to as the statistical or quantitative breeding method. In the statistical method 
of estimating narrow-sense heritability, 𝜎?̅?…𝑙
2  is composed of the following terms: 
𝜎?̅?…𝑙
2 =
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+
𝜎𝑒
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where 𝜎𝑌
2 is the overall variance of year, 𝜎𝐸
2 is the overall variance of environment, 𝜎𝑌𝐸
2  is the 
overall variance of the year-environment combination, 𝜎𝑅
2 is the overall variance of replication, 
𝜎𝐺
2 is the overall variance of genotype, 𝜎𝑌𝐺
2  is the overall variance of the year-genotype 
combination, 𝜎𝐸𝐺
2  is the overall variance of the environment-genotype combination, 𝜎𝑌𝐸𝐺
2  is the 
overall variance of the year-environment-genotype combination, i is the number of years, j is the 
number of environments, and k is the number of replications. This method takes into account all 
variance components, and therefore it produces results that vary from those of the plant breeding 
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method (Littell, Milliken, Stroup, Wolfinger, & Schabenberger, 2006). Both methods of 
estimating narrow-sense heritability were used and reported. 
RESULTS AND DISCUSSION  
BARLEY YELLOW DWARF VIRUS STUDY 
The primary objective of this study was to determine if there was a correlation between 
BYDV tolerance and AVN concentration, which will determine if BYDV tolerance can be used as 
an indirect selection method for AVN concentration. This relationship is of interest because it 
would be beneficial if BYDV tolerance could be used as an indirect selection method for AVN 
concentration as BYDV tolerance is relatively easy to phenotype while AVN concentration is 
time-consuming to phenotype. Stress in general has been shown to influence AVN concentration 
and BYD causes stress on infected plants. Figure 2.5 shows the distribution of the BYDV 
tolerance ratings averaged across both years and demonstrates that the population does an 
adequate job of sampling the range of BYDV tolerance reactions.  This question was investigated 
using the correlations between BYDV tolerance BLUPs and AVN concentrations BLUPs, which 
were calculated as previously described. A table of these correlations can be seen in Table 2.1. 
The four correlations between BYDV tolerance and AVN concentrations were all consistently 
low. The correlation between BYDV tolerance and AVN 2c was positive with 𝜌 = 𝑟 =0.00252. 
The correlation between BYDV tolerance and AVN 2p was positive with 𝜌 = 𝑟 =0.01330. There 
was a positive correlation between BYDV tolerance and AVN 2f with 𝜌 = 𝑟 =0.014. The 
correlation between BYDV tolerance and the total AVN concentration was positive with 𝜌 =
𝑟 =0.01123. The total AVN concentration of the genotypes was calculated by summing their 
AVN 2c, AVN 2p, and AVN 2f concentration averages. This method of calculating the total 
AVN concentration for a genotype is not completely accurate as additional AVNs are present in 
oats; however, as stated earlier AVN 2c, 2p, and 2f account for the majority of AVN 
concentration making this a good approximation of total AVN concentration (M. L. Wise, 
Doehlert, & McMullen, 2008). When the proportion of the total AVN concentration that is 
accounted for by AVN 2c, 2p and 2f was estimated using the collected data they were found to 
account for approximately 28% of the total AVN concentration.  
All of these correlations were highly non-significant based on the p-values for each 
correlation, which can be seen in Table 2.1. A potential explanation of the non-significant 
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correlation between BYDV tolerance and grain AVN concentration may be in the pathogen itself. 
In the case of crown rust, the causal pathogen is an obligate rust fungus Puccinia coronata var. 
avenae. The correlation between crown rust tolerance and grain AVN concentration is thought to 
potentially be due to the hypersensitive response (M. L. Wise et al., 2008). Phytoalexins, which 
are substances produced by plant tissues in response to contact with a parasite, have for some 
time been considered to play an important role is disease tolerance due to their fungitoxicity 
(Mayama et al., 1982). The fungitoxicity results in the plant hypersensitive response, which is 
rapid localized cell death around the region of infection, to microbial pathogens (M. L. Wise et 
al., 2008). Supporting evidence that AVNs act as phytoalexins in the plant hypersensitive 
response to P. coronata var. avenae is that AVN biosynthesis is induced by fungal infections or 
mimics of fungal infection (M. L. Wise et al., 2008). In addition, avenalumins, which AVNs are 
the open ring structure of, have been shown to be produced by oat in response to infection by P. 
coronata var. avenae (Mayama et al., 1982). Barley Yellow Dwarf Virus infection results from 
the persistent feeding of the aphid Rhopalosiphum padi on oat tissue (Foresman et al., 2016) and 
does not induce a plant hypersensitive response (Jin et al., 1998). The differences in the infection 
processes and plant responses between crown rust and BYD may account for why a similar 
relationship was not seen between BYDV tolerance and grain AVN concentration as was 
previously described between crown rust tolerance and grain AVN concentration. As there was 
no significant correlation between BYDV tolerance and AVN concentration it would be unwise to 
implement BYDV tolerance as an indirect selection method for AVN concentration. If such a 
measure was taken little to no progress would be made toward increasing AVN concentration 
due to the selection method being inefficient.  
DIVERSITY STUDY 
The first objective of the diversity study was to assess the overall AVN concentration 
diversity of the UIUC oat breeding program. Summary tables of all traits for the 100 genotypes 
from 2017, 2018, and the two years averaged can be found in Table A.1, Table A.2, and Table 
A.3 in Appendix A. The concentration of AVN 2c for a genotype was determined by averaging 
the phenotypic data collected from the HPLC analysis of that genotype across the three 
environments from both years. The AVN 2c concentration average was calculated for all 
genotypes, which allowed the range of AVN 2c concentration seen in the population to be 
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determined. The population had an AVN 2c concentration range of 4.02 – 31.12 𝜇𝑔/𝑔 dry 
weight groat tissue. The same process of averaging the genotypes’ phenotypic data across the 
three environments from both years was repeated in order to determine the population’s range of 
AVN 2p concentration and AVN 2f concentration. The population had an AVN 2p concentration 
range of 2.51 – 38.97 𝜇𝑔/𝑔 and an AVN 2f concentration range of 2.79 – 48.62 𝜇𝑔/𝑔. The total 
AVN concentration of the genotypes was calculated by summing their AVN 2c, AVN 2p, and 
AVN 2f concentration averages, giving the population a total AVN concentration range of 9.81 – 
112.51 𝜇𝑔/𝑔. This method of calculating the total AVN concentration for a genotype is not 
completely accurate as additional AVNs are present in oats; however, as stated earlier AVN 2c, 
2p, and 2f account for the majority of AVN concentration making this a good approximation of 
total AVN concentration (M. L. Wise, Doehlert, & McMullen, 2008). When the proportion of the 
total AVN concentration that is accounted for by AVN 2c, 2p and 2f was estimated using the 
collected data they were found to account for approximately 28% of the total AVN 
concentration. The distributions for all AVN concentrations can be seen in Figure 2.6, which 
provides a visual demonstration that the UIUC oat breeding germplasm has a diverse range of 
AVN concentration for all AVNs investigated. The diversity or range of AVN concentration 
present in a population or breeding program is important as diversity is necessary to make 
progress for increased trait values. The range of AVN concentration seen in the UIUC oat 
breeding program is of sufficient size to suggest that selection for increased AVN concentration 
would be possible with the existing germplasm as the highest genotype is approximately 11 
times greater than the lowest genotype.   
Variation in the proportions of the three AVNs based on HPLC output was observed 
across genotypes, which can be seen when Figures 2.1-2.4 are examined. This led to asking if 
genotypes that performed well for AVN 2c concentration also performed well for AVN 2p, AVN 
2f, and total AVN concentration. This query was investigated using the correlations between all 
AVN concentrations based on combined data, 2017 data, and 2018 data; as well as, by 
comparing the top and bottom performing genotypes, averaged across the three environments 
from both years, for all traits (AVN 2c, AVN 2p, AVN 2f, and total AVN concentration) which 
are shown in Table 2.2 and Table 2.3, respectively. The correlations between AVNs based on 
combined data, which can be seen in Table 2.4, showed that AVN 2c, AVN 2p, and AVN 2f 
were all significantly correlated to total AVN concentration. This is unsurprising and is an 
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artifact of how total AVN concentration was estimated. Examination of Table 2.4 shows that all 
AVNs are significantly correlated with one another, which is unsurprising as the three AVNs are 
similar in chemical structure and probably have very similar biochemical pathways. AVN 2c is 
more highly correlated with AVN 2p than with AVN 2f suggesting that AVN 2f tends be more 
unique in its behavior among the AVNs studied. The conclusions drawn from the combined data 
correlations are mirrored in the correlations among the AVNs based on the 2017 data and 2018 
data, which are shown in Table 2.5 and Table 2.6, respectively. These highly significant 
correlations suggest that while there was visual variation in AVN proportions among genotypes, 
genotypes that are high for one AVN concentration tend to be high for the other AVN 
concentrations as well.  When the top performing genotypes for the traits were compared, 4 of 
the 17 genotypes present in the table appeared in the top 10% for all four traits, while 8 of the 17 
genotypes appeared in the top 10% of at least three of the traits with genotypes changing rank 
among traits. It is interesting to note in Table 2.2 that  IL09-6934, which is the sister line of a 
genotype that is known to have high AVN concentration, was one of the 4 genotypes that 
consistently appeared in the top 10% for all four traits. When the bottom performing genotypes 
for the traits were compared, 6 of the 16 genotypes present in the table 2.3 appeared in the 
bottom 10% for all four traits, while 7 of the 16 genotypes appeared in the bottom 10% for at 
least three of the traits with a change in rank among traits. The results displayed in Table 2.2 and 
Table 2.3 suggested that even though there was visual variation of the proportion of AVNs 
between samples based on observation of HPLC output figures, when averaged across 
environments and years genotypes performed consistently across the four traits investigated. This 
observation is important as it indicates that a genotype that performs high for one AVN 
concentration will perform high for the other AVN concentrations. Perhaps more importantly 
this observation suggests that genotype is an important factor in the determination of AVN 
accumulation, which has important implications for breeding. The conclusions that genotypes 
perform consistently among the AVN concentrations based on comparison of averages are 
supported by the correlations among AVNs that have already been discussed. These conclusions 
also support the results reported by (Peterson et al., 2005). Genotypes were also performing 
similarly at the top and bottom range of AVN concentration with 47% and 44% of the genotypes 
present appearing in the top and bottom 10% for at least three of the traits, respectively. 
Knowledge about whether genotypes perform consistently across AVNs is of value to plant 
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breeders for selection and crossing purposes. If one genotype expresses high AVN 2c 
concentration but low AVN 2p concentration then that genotype could be crossed to another 
genotype that expresses high AVN 2p concentration in order to increase total AVN 
concentration.  
The second primary objective of this study was to determine if AVN concentrations were 
influenced by environmental factors. If genotypes perform consistently across environments is 
pertinent information for plant breeders as well. Change in rank genotype by environment 
interactions make selection for increased levels of a trait more difficult. A genotype that is not 
stable across environments for a trait is often undesirable or must be carefully marketed for the 
target region in which it performs best. In order to assess if genotypes performed consistently for 
AVN concentration the phenotypic data for each genotype from each location were averaged 
across both years. The comparisons of the top performing genotypes across locations for AVN 
2c, AVN 2p, AVN 2f, and total AVN concentrations are shown in Table 2.7, Table 2.8, Table 
2.9, and Table 2.10, respectively. When AVN 2c concentration was compared across the three 
environments, 3 of the 21 genotypes present in Table 2.7 appeared in the top 10% at all three 
environments, and 6 of the 21 genotypes appeared in the top 10% at two of the environments. 
The comparison of AVN 2p concentration across environments showed that 7 of the 15 
genotypes present in Table 2.8 appeared in the top 10% at all three environments, and 8 of the 15 
genotypes were in the top 10% at two environments. When AVN 2f concentration was compared 
across environments, 4 of the 14 genotypes present in Table 2.9 were in the top 10% at all three 
environments, and 12 of the 14 genotypes appeared in the top 10% at two of the environments. 
The comparison of total AVN concentration showed that 4 of the 17 genotypes present in Table 
2.10 appeared in the top 10% at the three environments, and 9 of the 17 genotypes were in the 
10% at two environments. Of the genotypes present in the comparison of the top performing 
genotypes for AVN 2c, AVN 2p, AVN 2f, and total AVN concentration 14%, 47%, 29%, and 
24% of the genotypes were conserved across all three environments indicating that there was 
variation in how genotypes performed among the environments. However, this variation appears 
to be primarily in relative amount of AVNs accumulated with genotypes reaching higher AVN 
concentrations at some environments than at others. The changes in rank of genotypes among 
environments are minimal suggesting that genotype may be the largest influence on AVN 
concentrations. It was again interesting to note that IL09-6934 was one of the genotypes that 
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appeared in the top 10% at all three environments for AVN 2c, AVN 2p, and total AVN 
concentration, while IL09-6937 appeared in the top 10% in all three environments for AVN 2f 
concentration. 
How a genotype performs for a trait across years is also valuable information for plant 
breeders to have at their disposal. If the trait value of a genotype is highly influenced by the year 
in which it is grown the success of selection over time may be affected. It is also very important 
for a genotype to perform consistently from one year to the next, because producers expect to see 
consistent quality from a cultivar. To compare a genotype’s performance across years, the 
genotype’s phenotypic data for each year was averaged across environments. The top performing 
genotypes compared across 2017 and 2018 for AVN 2c, AVN 2p, AVN 2f, and total AVN 
concentration are shown in Table 2.11, Table 2.12, Table 2.13, and Table 2.14, respectively. The 
comparison of AVN 2c concentration across years resulted in 5 of the 15 genotypes present in 
Table 2.11 appearing in the top 10% in both years. When AVN 2p concentration was compared 
across years, 8 of the 12 genotypes present in Table 2.12 appeared in the top 10% in both years. 
Comparing AVN 2f concentration across the two years also resulted in 8 of the 12 genotypes 
present in Table 2.13 appearing in the top 10% in both years. Total AVN concentration when 
compared across years showed that 7 of the 13 genotypes present in Table 2.14 appeared in the 
top 10% in both years. These four comparisons suggested that the rank of genotypes for AVN 
2p, AVN 2f, and total AVN concentration were relatively unaffected by year as 67%, 67%, and 
54% of the genotypes in their respective comparisons appeared in the top 10% in both years. 
Year does not appear to be affecting the performance of genotypes for the traits, but rather the 
relative level of AVNs accumulated by all genotypes. It is unsurprising that genotypes performed 
relatively similar for AVN 2p, AVN 2f, and total AVN in both years when the correlations 
among these AVN concentrations from 2017 and 2018 are examined in Table 2.15. These AVNs 
are highly correlated with themselves between the two years.  The same was not true for AVN 
2c, with only 33% of the genotypes in the comparison appearing in the top 10% in both years, 
which suggested that AVN 2c may be the most affected by variation in growing season 
conditions. This trend of AVN 2c potentially being more susceptible to seasonal variation 
compared to the other AVNs can be seen when its correlation with itself between the two years is 
observed in Table 2.15. While AVN 2c has the lowest correlation with itself compared to how 
the other AVNs correlate with themselves between years, AVN 2c is still highly correlated with 
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itself. The observations of AVN 2c are still suggesting that year influences the relative amount of 
AVNs accumulated rather than how a genotype ranks in performance. Year appears to influence 
the relative amount of AVN 2c more than the relative amount of the other AVNs. IL09-6934 
again appeared in the top 10% in both years for all AVN concentrations further suggesting that it 
performs high in AVN concentration across AVNs, environments, and years.  
While all the comparisons discussed so far in this paper provide useful and informative 
information, they were based on averages of raw data and needed to be further validated. The 
trends observed from all comparisons were validated through the statistical analysis described 
previously. The statistical analysis also allowed for investigation into the influence of 
environment and year on AVN concentration. The parameter estimates yielded from the 
statistical analysis of AVN 2c concentration are displayed in Table 2.16. When the parameter 
estimates were examined, genotype, the year-by-genotype interaction, the environment-by-
genotype interaction, and the year-by-environment-by-genotype interaction provided significant 
variance component estimates. In particular the variance component estimates for genotype and 
the year-by-genotype interaction, which were 0.1598 (p-value = <0.0001) and 0.02292 (p-value 
= 0.0014), respectively, were found to be highly significant suggesting that these variance 
components had the greatest influenced on AVN 2c concentration. While all interactions must be 
investigated before conclusions about main effects, such as genotype, can be made, the large Z 
score value seen for genotype ( Z score = 5.58) suggested that genotype did influence AVN 2c 
concentration. All significant interactions were assessed in hierarchical order using the variance 
component estimates and the profile plots described in the Statistical Analysis section of this 
chapter.  
The significant three-way interaction suggested that genotypes changed rank or had a 
different magnitude of response between year-environment combinations. Examination of the 
three-way profile plots for AVN 2c concentration, which can be seen in Figure 2.7, showed that 
the latter was true. Genotypes expressed different magnitudes of response based on the year-
environment combination. Higher concentrations of AVN 2c were produced in 2018 than in 
2017 supporting the observation made previously that year influenced the relative amount of 
AVN accumulation. There was also a change in rank for environments between 2017 and 2018. 
In 2017 the environments ranked in the following order, with the BYDV nursery producing the 
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highest levels followed by Monmouth, IL, and then Urbana, IL. In comparison the BYDV nursery 
produced the highest levels followed by Urbana, IL then Monmouth, IL in 2018. This further 
indicated that environments differed across years. Given that environmental conditions between 
the two field seasons were noticeably different this conclusion was expected. The 2017 field 
season was comparably normal for central Illinois, with the early spring being cool and rainy 
followed by warmer and drier conditions in early summer. The 2018 season was considerably 
different with early spring being abnormally cold with snow accumulation occurring into the 
middle of March followed by a hot and dry period, and then cooler and rainier conditions than 
normal in early summer. The environmental conditions in 2018 most likely explain the change in 
rank of environments; as well as, why the BYDV nursery and Urbana, IL environments 
performed in such a similar manner in 2018. Both the BYDV nursery and Urbana, IL 
environment were planted on the CSREC at UIUC. In 2018 four inches of snow accumulated just 
after sowing on the CSREC followed dry conditions and emergence of seedlings was not 
observed for six weeks. This stress on the CSREC environments could have stimulated AVN 2c 
accumulation to similar extents in both environments as they were geographically similar. While 
environments varied between years, environment’s influence on AVN concentrations appeared 
to be on the level of concentration produced rather than on the rank of genotype performance. 
Perhaps the most important observation from the three-way interaction profile plots was that 
genotypes performed consistently across environments in both years. This is best explained using 
the phrase ‘where there are peaks there are peaks and where there are troughs there are troughs’, 
meaning that there was little change in rank for genotypes between environments within a year 
again suggesting that the genotypic control of the traits is strong.  
Conclusions drawn from investigation of the year-by-genotype interaction profile plot of 
AVN 2c shown in Figure 2.8 supported the conclusions based on the three-way interaction 
profile plots that were just discussed. A significant year-by-genotype interaction variance 
component estimate indicates that genotypes changed rank or expressed a different magnitude of 
response between years. Genotypes expressed different magnitudes of response with 2018 
producing higher AVN 2c concentrations levels than 2017. This observation indicated that year 
influenced the relative amount of AVN 2c concentration and supported the conclusions drawn 
from the three-way interaction profile plots. The conclusion based on the year-by-genotype 
interaction was probably due to the difference in environmental conditions between 2017 and 
41 
 
2018, which have already been discussed. The environment-by-genotype interaction of AVN 2c 
was marginally significant with a variance component estimate of 0.01752 (p-value = 0.0227) 
suggesting that genotypes changed rank or had different magnitudes of response between 
environments. Examination of this interaction’s profile plot (Figure 2.9) showed that some 
genotypes expressed a change in rank between environments, though these changes in rank were 
of a very small magnitude. Most genotypes did not express a change in rank between 
environments and the magnitude of difference in response between environments was also small. 
When all the results for AVN 2c were compiled, they could be summarized by saying that AVN 
2c concentration was influenced by year, environment, and genotype with year and genotype 
having larger influence on the trait than environment and that genotypes performed consistently 
across environments independent of year in nearly all cases. The profile plot of the year-by-
environment interaction for AVN2c can be seen in Figure A.1. in Appendix A, but is not 
discussed here as this interaction was not significant. 
The results of the statistical analysis of AVN 2p concentration led to similar conclusions 
as those drawn for AVN 2c concentration. The variance parameter estimates for the AVN 2p 
analysis, which can be seen in Table 2.17, that were found to be significant were genotype with 
an estimate of 0.2406 (p-value = <0.0001) and the year-by-genotype interaction with an estimate 
of 0.02576 (p-value = 0.0042). The fact that all variance parameters involving environment were 
found to be non-significant suggested that if environment was influencing AVN 2p concentration 
that influence was marginal. While genotype is a main effect, the large Z score (Z score = 6.07) 
associated with it suggested that genotype had a strong influence on AVN 2p concentration, 
though interactions needed to be assessed before a final conclusion was made. The three-way 
interaction between year, environment, and genotype for AVN 2p can be seen in Figure A.2 in 
Additional Tables and Figures, but is not discussed here as this interaction was not significant. 
The significant year-by-genotype interaction suggested that genotypes expressed a change in 
rank or a difference in the magnitude of response between 2017 and 2018. The examination of 
the profile plot for the year-by-genotype interaction, which can be seen in Figure 2.10, indicated 
that the second explanation for its significance was true. Similar to the results of AVN 2c 
concentration, 2018 produced larger AVN 2p concentrations than 2017 most likely due to the 
seasonal differences between the two years, which have been discussed previously. Other 
pertinent information that can be observed from Figure 2.10 is that much like the case of AVN 
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2c concentration, genotypes performed consistently across years without changes in rank 
between years. This led to the conclusion that year influenced the relative amount of AVN 2p. 
The profile plots for the environment-by-genotype interaction and the year-by-environment 
interaction for AVN 2p can be seen in Figure A.3 and Figure A.4 of Appendix A, but are not 
discussed here as neither of these interactions were significant. It was interesting to note that, 
though the differences is not drastic, AVN 2p concentration levels were lower than AVN 2c 
concentration levels in both 2017 and 2018. Summarizing the results for AVN 2p concentration 
led to the following conclusions. Similar to AVN 2c, AVN 2p concentration was influenced by 
the year in which genotypes were grown and by the genotypes themselves. Genotypes performed 
consistently across years, which suggested that genotype was indeed having an influence on the 
trait.  Avenanthramide 2p concentration appeared to be relatively unaffected by environment 
when compared to AVN 2c. In summary, year and genotype appeared to have influenced AVN 
2p concentration to the largest extent with genotype having a stronger influence on genotypic 
rank and year influencing the level of concentration reached.  
Analysis of AVN 2f concentration yielded results very similar to those of AVN 2p. The 
significant parameters in the AVN 2f analysis were genotype and the year-by-genotype 
interaction with variance component estimates (Table 2.18) of 0.2599 (p-value = <0.0001) and 
0.02107 (p-value = 0.0147), respectively.  Genotype is a main effect and therefore conclusions 
could not be drawn about it until significant interactions were assessed; however, the large Z 
score associated with genotype (Z score = 6.16) indicated that there was high likelihood that 
genotype influenced AVN 2f concentration. The profile plot of the year-by-environment-by-
genotype interaction for AVN 2f can be seen in Figure A.5, but is not discussed here as this 
three-way interaction was not significant. The significant year-by-genotype interaction suggested 
that genotypes expressed a change in rank or a difference in the magnitude of response between 
2017 and 2018. Examination of the profile plot for the year-by-genotype interaction, which can 
be seen in Figure 2.11, showed that the latter is true with AVN 2f concentration reaching higher 
levels in 2018 than in 2017. This difference in magnitude of response was again most likely due 
to the dissimilar growing seasons experienced in the two years. Much like the other two AVNs, 
genotypes appeared to perform consistently across the two years without many changes in rank. 
In addition to the significance of genotype and the year-by-genotype interaction, it was telling 
that no parameters involving environment were found to be significant. The profile plots for the 
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environment-by-gentoype interaction and the year-by-environment interaction for AVN 2f can 
be seen in Figures A.6 and Figure A.7, respectively, but are discussed about here as these two 
way interactions were not significant. It was interesting to note that, though the differences were 
again not drastic, AVN 2f concentration levels were lower than AVN 2c and AVN 2p 
concentration levels in both 2017 and 2018. When all the information from the AVN 2f analysis 
was taken into account it led to the conclusion that the trait was predominantly influenced by 
year and genotype with any environmental influence within a year on the trait being marginal. 
The conclusion of the primary influences on AVN 2f concentration mirrored those of AVN 2p 
specifically, but also shared similarities with AVN 2c. 
The total AVN concentration analysis produced results that were most similar to the 
results of AVN 2c. The total AVN concentration was approximated by adding AVN 2c, AVN 
2p, and AVN 2f concentrations together. The variance parameter estimates of the total AVN 
concentration analysis are shown in Table 2.19. The parameters found to be significant were 
genotype, the year-by-genotype interaction, and the environment-by-genotype interaction which 
had variance estimates of 0.2071 (p-value = <0.0001), 0.02520 (p-value = 0.0041), and 0.01471 
(p-value = 0.0481), respectively. Once again the large Z score associated with the main effect of 
genotype (Z score = 5.93) indicated that total AVN concentration was primarily influenced by 
genotype; however, significant interactions had to be investigated before this conclusion was 
made with confidence. The profile plot for the year-by-environment-by-gentoype interaction for 
total AVN concentration can be seen in Figure A.8 of Appendix A, but is not discussed here as 
this three-way interaction was not significant. The fact that the year-by-genotype interaction was 
found to be significant suggested that genotypes experienced a change in rank or a difference in 
the magnitude of response between 2017 and 2018. When the profile plot of the year-by-
genotype interaction for total AVN concentration, which is shown in Figure 2.12, was assessed, 
it became apparent that the latter explanation was accurate. Much like for the three other AVN 
concentrations investigated, total AVN concentration achieved higher levels in 2018 than in 
2017 with genotypes not changing rank between the two years. This suggested that year 
influenced total AVN concentration, but genotype influenced the trait as well. The environment-
by-genotype interaction was barely significant which is somewhat apparent when the profile plot 
for the interaction, which can be found in Figure 2.13, was examined. A significant environment-
by-genotype interaction suggested that genotypes changed rank or had different magnitudes of 
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response between environments. The profile plot indicated that select genotypes changed ranks 
dependent on the environment where they were grown. These changes in rank were of a very 
small magnitude, which suggested that while environment influenced total AVN concentration it 
did so to a marginal extent. The profile plot of the year-by-environment interaction of total AVN 
concentration can be seen in Figure A.9 in Appendix A, but is not discussed here as this 
interaction was not significant. Summarizing the statistical results for total AVN concentration 
resulted in conclusions very reminiscent of the conclusions for the other AVN concentrations. 
Similar to all other AVN concentrations, total AVN concentration appeared to be most 
influenced by year and genotype. The influence of year was to be expected as the 2017 growing 
season was quite dissimilar from the 2018 growing season. Like AVN 2c, total AVN 
concentration appeared to be marginally influenced by environment though to a lesser extent.  
The statistical results for all AVN concentrations validated the observations drawn from 
the preliminary comparison of averages. All AVNs appeared to be under relatively strong 
genotypic control with year also influencing concentration levels in a predictable manner. 
Environment was also found to have an influence on AVN concentrations with that influence 
being more apparent for AVN 2c concentration and total AVN concentration. In all cases the 
influence of environment on AVN concentration appeared to be relatively marginal and to 
impact the relative concentration of AVNs and not genotypic rank. This is in contrast to previous 
studies which indicated a major effect of environment on AVN concentration (Emmons & 
Peterson, 2001; Peterson et al., 2005; M. L. Wise et al., 2008). These results suggested that the 
heritability of AVN concentrations should be adequate to achieve genetic gain through selection. 
The third objective of this study was to confirm this postulation by estimating the heritability of 
AVN concentrations. Heritability estimations using the plant breeding formula, which was 
described previously in the Statistical Analysis section, led to high estimated heritability rates. 
Heritability was estimated to be 0.82, 0.88, 0.89, and 0.86 for AVN 2c, AVN 2p, AVN 2f, and 
total AVN concentration, respectively, which are quite high. The plant breeding method of 
estimating heritability led to such high numbers in this case because it only took into account 
variation in the dataset that involved genotypic variation. This meant that variation that was due 
to year and environment was left mostly unaccounted for (Bernardo, 2010; Dudley & Moll, 
1969). It was decided that heritability of the AVN concentrations should also be estimated using 
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the previously described statistical formula, because how a trait varies between years and 
environments is vital information for plant breeding and selection. 
The statistical formula resulted in estimated heritability rates that were more 
characteristic of traits similar to AVN concentration. The estimated heritability of AVN 2c, AVN 
2p, AVN 2f, and total AVN concentration were found to be 0.34, 0.39, 0.41, and 0.37, 
respectively, using this formula. All of the heritability estimates can be found in Table 2.20. The 
statistical method of estimating narrow-sense heritability produced lower numbers than the plant 
breeding method because it took into account the variation in the dataset that was due to year and 
environment factors and the interaction between the two (Littell et al., 2006). The inclusion of 
the variation due to year was probably the predominant cause of the lower estimated heritability 
rates as the year main effect had large variance parameter estimates for all AVN concentrations. 
While these heritability estimations are considerably smaller than the heritability estimations 
obtained from the plant breeding formula, selection progress could still be made for increased 
AVN concentration based on the statistical narrow-sense estimated heritability rates.  
The compilation of all the results of the diversity study can be condensed to answer one 
question, which is “Is selection for increased AVN concentration in spring oat possible?” The 
answer to this question simply put is “Yes”. The comparison of averages suggested that 
genotypes performed relatively consistently across environments and years indicating that AVN 
concentration was under genetic control, which was further verified by statistical analysis. This 
does not mean that environment and year did not influence the trait. In fact, the opposite was true 
especially in the case of year. While genotypes performed relatively consistently across years 
based on the comparison of averages, the relative level of AVN concentrations varied between 
years. The influence of year on AVN concentration was also apparent in the statistical analysis as 
a change in magnitude of response, with higher concentrations being expressed in 2018 
regardless of genotype or environment. The influence of environment was more apparent for 
AVN 2c concentration and total AVN concentration than the other AVN concentrations. In terms 
of the comparison of means, the influence of environment was seen in the small changes of rank 
of the genotypes among environments and in the relative amount of AVN concentration 
achieved. The statistical analysis showed the influence of environment via changes in magnitude 
of response among environments with the BYDV nursery consistently producing the highest 
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AVN concentration levels, and in marginal changes in rank of selected genotypes among 
environments. While year and environment influenced AVN concentrations the relatively strong 
genotypic control over the trait was reinforced by the estimated heritability rates obtained. In 
summary the results indicate that selection for increased AVN concentration in spring oat is 
possible. It is also interesting to note that year and environment appeared to influence AVNs 
primarily in the level of accumulation achieved and not the ranked performance of genotypes. 
This has interesting implication from a plant breeding viewpoint as it suggests that phenotyping 
genotypes for AVN concentration at a single location in a single year may provide sufficient 
information for a breeder to make decisions of which genotypes to cross to increase AVN 
concentration.   
CONCLUSIONS AND FUTURE WORK    
The conclusions of the BYDV study, which were that BYD tolerance and AVN 
concentration were not significantly correlated and therefore BYD tolerance cannot be used as an 
indirect selection method for AVN concentration, led to one of the future avenues of research for 
this project. It would be beneficial to know if other traits that are easily phenotyped are 
correlated with AVN concentration. If such traits exist they could be used to indirectly select for 
AVN concentration, which would allow the time and resource expensive phenotyping of AVNs 
to be avoided. Based on the diversity study, AVN concentrations are under strong genotypic 
control and therefore are reasonably heritable. The analysis of AVN concentrations in the 
diversity study which included 100 genotypes provided evidence that the UIUC germplasm is 
variable for AVN concentration and that breeding progress for higher AVN concentration should 
be possible. This in turn means that the nutritional value of food products containing oats can be 
improved. Avenanthramides provide numerous health benefits, which were discussed in Chapter 
1, including antioxidant, anti-inflammatory, and anti-proliferative activities. These biological 
activities provided by AVNs, which benefit human health, have be found to be dose-dependent; 
therefore, increasing AVN concentration in oat cultivars will increase the AVN concentration of 
food products and provide improved health benefits to consumers. The limiting factor in 
breeding oat cultivars with increase AVN concentration is the time and expense required for 
phenotypic AVN. If a larger population that is more representative of the UIUC oat breeding 
program could be developed, genotyped, and phenotyped for AVNs, a genomic selection model 
could be constructed. The genomic selection model would allow for the prediction of AVN 
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concentrations of genotypes and a reduction in the number of genotypes that would have to be 
phenotyped for AVN concentration each year. A genome-wide association mapping study to try 
to identify QTL and candidate genes that control AVN concentration is also of interest. Another 
interesting future research project would be to try to identify if a particular environmental factor 
accounts for the changes in the relative level of AVN concentration between years and 
environments.  
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TABLES 
 
Table 2.1. Correlations between avenanthramide (AVN) concentrations BLUPs and Barley 
Yellow Dwarf Virus (BYDV) severity rating BLUPs. The top number in each cell is the 
correlation value and the bottom number in each cell is the p-value of the correlation. 
 
Pearson Correlation Coefficients, N = 100  
Prob > |r| under H0: Rho=0 
  AVN c AVN p AVN f Total AVN BYDV rating 
AVN c 1.00000 
  
 
0.87966 
<.0001 
 
0.82331 
<.0001 
 
0.93838 
<.0001 
 
0.00252 
0.9801 
 
AVN p  
 
 
1.00000 
  
 
0.93070 
<.0001 
 
0.97948 
<.0001 
 
0.01330 
0.8955 
 
AVN f  
 
 
 1.00000 
  
 
0.95592 
<.0001 
 
0.01400 
0.8900 
 
Total AVN  
 
 
  1.00000 
  
 
0.01123 
0.9117 
 
BYDV rating  
 
 
   
 
 
1.00000 
  
 
 
 
 
 
 
 
 
 
 
 
49 
 
Table 2.2. Top ten percent of spring oat genotypes based on avenanthramide 2c (AVN 2c), avenanthramide 2p (AVN 2p), 
avenanthramide 2f (AVN 2f), and total avenanthramide (Total AVN) concentration where concentrations are averaged across all 
environments and years. Genotypes that appeared in the top 10% for multiple AVN concentrations have been highlighted in the same 
color across said concentrations.  
 
Genotype 
AVN 2c 
(𝝁𝒈/𝒈) 
Genotype 
AVN 2p 
(𝝁𝒈/𝒈) 
Genotype 
AVN 2f 
(𝝁𝒈/𝒈) 
Genotype 
Total AVN 
(𝝁𝒈/𝒈) 
09-6934 31.12 12-12821 38.97 11-5728 48.62 11-5728 112.16 
12-7401 30.17 11-5728 33.95 MN06203 34.71 09-6934 85.37 
11-5728 29.59 12-12805 30.35 11-5748 30.69 11-5748 83.51 
12-7416 28.61 MN05155 29.99 MN05155 29.30 12-12821 82.35 
11-5748 27.35 MN06203 27.41 09-6934 28.30 MN05155 79.96 
12-7556 25.91 09-6934 25.94 11-7655 24.59 MN06203 76.00 
11-6458 24.28 11-5748 25.47 SD110466 24.19 12-7401 72.82 
Reins 24.25 Reins 22.55 09-6937 23.58 Reins 70.22 
11-6459 23.93 12-7401 22.44 Reins 23.43 12-12805 63.92 
12-7430 23.17 11-7655 21.31 12-12821 22.45 12-7416 62.96 
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Table 2.3. Bottom ten percent of spring oat genotypes based on avenanthramide 2c (AVN 2c), avenanthramide 2p (AVN 2p), 
avenanthramide 2f (AVN 2f), and total avenanthramide (Total AVN) concentration where concentrations are averaged across all 
environments and years. Genotypes that appeared in the bottom 10% for multiple AVN concentrations have been highlighted in the 
same color across said concentrations.  
 
 
 
Genotype 
AVN 2c 
(𝝁𝒈/𝒈) 
Genotype 
AVN 2p 
(𝝁𝒈/𝒈) 
Genotype 
AVN 2f 
(𝝁𝒈/𝒈) 
Genotype 
Total 
AVN 
(𝝁𝒈/𝒈) 
BT1020-1-1 4.02 11-6317 2.51 11-6317 2.79 11-6317 9.81 
11-6317 4.52 08-7031 3.82 09-1126 3.35 08-7031 12.29 
09-1126 4.87 Blaze 4.02 08-7031 3.36 09-1126 12.80 
08-7031 5.11 09-1126 4.62 Buckskin 3.99 Blaze 13.32 
Blaze 5.14 09-3929 4.96 12-9020 4.02 SD031128 17.35 
SD031128 5.62 SD031128 5.16 Blaze 4.16 09-3929 17.60 
Excel 6.42 12-7166 5.45 09-3929 5.09 Ogle 18.21 
Ogle 6.99 Ogle 5.51 12-7166 5.13 12-9020 18.96 
10-9867 7.06 12-6448 5.73 08-9435 5.51 BT1020-1-1 19.28 
09-3929 7.55 Clintland-64 5.78 Ogle 5.71 Buckskin 19.46 
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Table 2.4. Correlations between avenanthramide (AVN) concentrations genotypic BLUPs from 
combined data from both 2017 and 2018. The top number in each cell is the correlation value 
and the bottom number in each cell is the p-value of the correlation. 
 
 
 
 
 
 
 
 
Table 2.5. Correlations between avenanthramide (AVN) concentrations BLUPs from data 
collected in 2017. The top number in each cell is the correlation value and the bottom number in 
each cell is the p-value of the correlation. 
 
 
 
 
 
 
 
 
 
 
Pearson Correlation Coefficients, N = 100  
Prob > |r| under H0: Rho=0 
  AVN 2c AVN 2p AVN 2f Total AVN 
AVN 2c 1.00000 
  
 
0.87450 
<.0001 
 
0.79846 
<.0001 
 
0.92525 
<.0001 
 
AVN 2p  1.00000 
  
 
0.93886 
<.0001 
 
0.98300 
<.0001 
 
AVN 2f   1.00000 
  
 
0.95746 
<.0001 
 
Total AVN    
 
 
1.00000 
  
 
Pearson Correlation Coefficients, N = 100  
Prob > |r| under H0: Rho=0 
  AVN 2c AVN 2p AVN 2f Total AVN 
AVN 2c 1.00000 
  
 
0.89286 
<.0001 
 
0.82930 
<.0001 
 
0.93787 
<.0001 
 
AVN 2p  1.00000 
  
 
0.94679 
<.0001 
 
0.98487 
<.0001 
 
AVN 2f   1.00000 
  
 
0.96281 
<.0001 
 
Total AVN    
 
 
1.00000 
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Table 2.6. Correlations between avenanthramide (AVN) concentration BLUPs from data 
collected in 2018. The top number in each cell is the correlation value and the bottom number in 
each cell is the p-value of the correlation. 
 
Pearson Correlation Coefficients, N = 100  
Prob > |r| under H0: Rho=0 
  AVN 2c AVN 2p AVN 2f Total AVN 
AVN 2c 1.00000 
  
 
0.85181 
<.0001 
 
0.75878 
<.0001 
 
0.91032 
<.0001 
 
AVN 2p  1.00000 
  
 
0.92896 
<.0001 
 
0.98062 
<.0001 
 
AVN 2f   1.00000 
  
 
0.94941 
<.0001 
 
Total AVN    
 
 
1.00000 
  
 
 
Table 2.7. Top ten percent of spring oat genotypes for avenanthramide 2c concentration based 
on environment where concentrations are averaged across years. Genotypes that appeared in the 
top 10% in multiple environments have been highlighted in the same color across said 
environments.  
 
Genotype BYDV Nursery 
(𝝁𝒈/𝒈) 
Genotype Monmouth 
(𝝁𝒈/𝒈) 
Genotype Urbana 
(𝝁𝒈/𝒈) 
11-5728 40.44 11-5748 22.49 12-7401 46.43 
09-6934 37.65 09-6934 20.48 12-7416 45.34 
12-7556 33.94 MN05155 19.83 12-7403 44.91 
12-5538 32.85 Reins 19.58 11-6459 38.15 
11-7728 31.88 12-7416 18.38 11-6458 37.80 
12-7401 30.66 12-7401 17.48 12-7556 37.35 
09-2968 30.38 11-5728 16.65 09-6934 36.61 
06-8153 29.22 12-12821 15.23 12-10307 32.86 
11-5748 28.76 SD111939 14.83 11-5728 32.37 
12-10931 28.36 12-12427 12.64 12-7430 32.03 
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Table 2.8. Top ten percent of spring oat genotypes for avenanthramide 2p concentration based 
on environment where concentrations are averaged across years. Genotypes that appeared in the 
top 10% in multiple environments have been highlighted in the same color across said 
environments.  
 
Genotype BYDV Nursery 
(𝝁𝒈/𝒈) 
Genotype Monmouth 
(𝝁𝒈/𝒈) 
Genotype Urbana 
(𝝁𝒈/𝒈) 
12-12821 53.14 MN05155 31.03 12-12805 49.55 
11-5728 43.01 12-12821 28.33 12-7401 39.60 
09-6934 30.26 MN06203 21.36 11-5728 39.07 
MN05155 28.37 11-5728 21.05 MN06203 34.61 
MN06203 28.07 11-5748 20.38 11-5748 33.15 
11-7655 28.04 12-12805 19.40 12-7416 32.36 
09-2968 27.65 Reins 18.23 12-12821 31.91 
12-5538 27.32 09-6934 17.92 09-6934 30.87 
12-12805 26.92 SD110466 16.73 MN05155 30.74 
11-5748 24.80 12-7401 12.68 12-5536 29.51 
 
 
Table 2.9. Top ten percent of spring oat genotypes for avenanthramide 2f concentration based on 
environment where concentrations are averaged across years. Genotypes that appeared in the top 
10% in multiple environments have been highlighted in the same color across said environments.  
 
Genotype BYDV Nursery 
(𝝁𝒈/𝒈) 
Genotype Monmouth 
(𝝁𝒈/𝒈) 
Genotype Urbana 
(𝝁𝒈/𝒈) 
11-5728 60.40 MN05155 31.02 11-5728 56.48 
MN06203 34.22 11-5728 30.96 11-5748 43.46 
11-7655 32.88 MN06203 30.94 09-6934 41.76 
12-5538 29.94 11-5748 22.77 MN06203 40.38 
12-10931 29.85 09-6934 21.63 Reins 31.33 
11-5748 29.02 SD110466 21.30 12-5536 31.31 
MN05155 28.59 Reins 19.08 12-7401 31.12 
09-6937 27.58 12-12821 17.70 SD110466 30.44 
12-5536 27.08 09-6937 15.99 11-7655 29.40 
12-12821 27.00 12-7401 13.61 09-6937 28.37 
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Table 2.10. Top ten percent of spring oat genotypes for total avenanthramide concentration 
based on environment where concentrations are averaged across years. Genotypes that appeared 
in the top 10% in multiple environments have been highlighted in the same color across said 
environments.  
 
Genotype BYDV Nursery 
(𝝁𝒈/𝒈) 
Genotype Monmouth 
(𝝁𝒈/𝒈) 
Genotype Urbana 
(𝝁𝒈/𝒈) 
11-5728 143.85 MN05155 81.88 11-5728 127.91 
12-12821 106.63 11-5728 68.66 12-7401 117.15 
09-6934 92.80 11-5748 65.64 09-6934 109.23 
12-5538 90.11 MN06203 62.64 11-5748 108.57 
09-2968 83.69 12-12821 61.27 12-7416 102.63 
11-7655 83.19 09-6934 60.03 12-12805 94.27 
11-5748 82.58 Reins 56.88 12-7403 93.83 
12-10931 81.89 SD110466 48.79 MN06203 90.82 
MN06203 78.24 12-7401 43.77 11-6459 89.45 
MN05155 77.92 12-12805 42.16 Reins 88.69 
  
 
Table 2.11. Top ten percent of spring oat genotypes for avenanthramide 2c concentration based 
on year where concentrations are averaged across environments within year. Genotypes that 
appeared in the top 10% in multiple years have been highlighted in the same color across said 
years. 
 
Genotype 2017 (𝝁𝒈/𝒈) Genotype 2018 (𝝁𝒈/𝒈) 
12-7416 16.86 12-7401 45.96 
11-5748 15.81 09-6934 45.85 
Reins 15.09 11-5728 42.50 
11-5728 14.09 11-6459 39.70 
09-6934 13.45 11-6458 39.52 
MN05155 12.60 12-7416 38.41 
12-5538 11.76 12-7556 37.86 
BT1021-1-1 11.63 12-7403 37.03 
12-7556 11.56 11-5748 36.97 
12-12821 11.34 12-7430 35.74 
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Table 2.12. Top ten percent of spring oat genotypes for avenanthramide 2p concentration based 
on year where concentrations are averaged across environments within year. Genotypes that 
appeared in the top 10% in multiple years have been highlighted in the same color across said 
years. 
 
Genotype 2017 (𝝁𝒈/𝒈) Genotype 2018 (𝝁𝒈/𝒈) 
12-12821 23.59 12-12821 54.35 
11-5728 17.25 11-5728 47.86 
MN05155 16.09 12-12805 42.77 
12-12805 15.45 MN05155 41.57 
MN06203 14.38 09-6934 38.32 
Reins 13.15 MN06203 38.27 
11-5748 12.10 11-5748 36.62 
SD110466 11.93 12-7401 34.13 
09-6934 11.08 11-7655 33.49 
11-2353 10.44 Reins 30.37 
 
 
 
 
Table 2.13. Top ten percent of spring oat genotypes avenanthramide 2f concentration based on 
year where concentrations are averaged across environments within year. Genotypes that 
appeared in the top 10% in multiple years have been highlighted in the same color across said 
years. 
 
Genotype 2017 (𝝁𝒈/𝒈) Genotype 2018 (𝝁𝒈/𝒈) 
11-5728 20.75 11-5728 71.85 
MN06203 18.51 MN06203 48.20 
MN05155 15.48 11-5748 45.33 
SD110466 13.71 09-6934 41.27 
11-5748 13.11 MN05155 40.81 
09-6934 12.75 11-7655 39.92 
12-12821 12.62 09-6937 35.37 
Reins 12.56 SD110466 34.67 
12-5538 11.57 Reins 32.48 
08-9452 11.05 12-12821 32.28 
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Table 2.14. Top ten percent of spring oat genotypes for total avenanthramide concentration 
based on year where concentrations are averaged across environments within year. Genotypes 
that appeared in the top 10% in multiple years have been highlighted in the same color across 
said years. 
 
Genotype 2017 (𝝁𝒈/𝒈) Genotype 2018 (𝝁𝒈/𝒈) 
11-5728 52.10 11-5728 162.21 
12-12821 47.55 09-6934 125.44 
MN05155 44.17 11-5748 118.92 
MN06203 42.70 12-12821 117.16 
11-5748 41.02 12-7401 109.83 
Reins 40.80 MN05155 109.79 
09-6934 37.28 MN06203 103.75 
12-7416 36.88 11-7655 96.23 
SD110466 34.94 Reins 94.74 
12-12805 32.71 11-6459 90.46 
   
 
Table 2.15. Correlations between avenanthramide (AVN) concentration BLUPs from data 
collected in 2017 and 2018. The top number in each cell is the correlation value and the bottom 
number in each cell is the p-value of the correlation. 
 
Pearson Correlation Coefficients, N = 100  
Prob > |r| under H0: Rho=0 
  AVN 2c 
2018 
AVN 2p 
2018 
AVN 2f 
2018 
Total AVN 
2018 
AVN 2c 
2017 
0.91670 
<.0001 
 
0.85472 
<.0001 
 
0.80509 
<.0001 
 
0.90163 
<.0001 
 
AVN 2p 
2017 
0.78856 
<.0001 
 
0.95809 
<.0001 
 
0.91627 
<.0001 
 
0.93945 
<.0001 
 
AVN 2f 
2017 
0.71014 
<.0001 
 
0.89661 
<.0001 
 
0.97209 
<.0001 
 
0.91113 
<.0001 
 
Total AVN 
2017 
0.82965 
<.0001 
 
0.93811 
<.0001 
 
0.93246 
<.0001 
 
0.95170 
<.0001 
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Table 2.16. Variance parameter estimates for avenanthramide 2c concentration in spring oat.  
 
Variance Parameter Estimates 
Variance Parameter Estimate Z Value Pr > Z 
Year 0.4751 0.63 0.2628 
Environment 0.02285 0.18 0.4296 
Replication (Year*Environment) 0.004966 1.22 0.1105 
Genotype 0.1598 5.58 <.0001** 
Year*Environment 0.1539 0.97 0.1649 
Year*Genotype 0.02935 2.99 0.0014** 
Environment*Genotype 0.01752 2.00 0.0227* 
Year*Environment*Genotype 0.02292 1.96 0.0248* 
Residual 0.1419 15.58 <.0001** 
**Highly significant at alpha 0.05 
*Significant at alpha 0.05 
  
 
Table 2.17. Variance parameter estimates for avenanthramide 2p concentration in spring oat.  
 
**Highly significant at alpha 0.05 
*Significant at alpha 0.05 
 
 
 
 
 
Variance Parameter Estimates 
Variance Parameter Estimate Z Value Pr > Z 
Year 0.6245 0.66 0.2545 
Environment 0.01755 0.17 0.4337 
Replication (Year*Environment) 0.005312 1.20 0.1158 
Genotype 0.2406 6.07 <.0001** 
Year*Environment 0.1258 0.96 0.1674 
Year*Genotype 0.02579 2.63 0.0042** 
Environment*Genotype 0.01232 1.39 0.0824 
Year*Environment*Genotype 0.01740 1.36 0.0865 
Residual 0.1668 15.59 <.0001** 
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Table 2.18. Variance parameter estimates for avenanthramide 2f concentration in spring oat.  
 
Variance Parameter Estimates 
Variance Parameter Estimate Z Value Pr > Z 
Year 0.6176 0.65 0.2592 
Environment 1.92E-20 . NS 
Replication (Year*Environment) 0.002820 0.96 0.1675 
Genotype 0.2599 6.16 <.0001** 
Year*Environment 0.1709 1.39 0.0823 
Year*Genotype 0.02107 2.18 0.0147* 
Environment*Genotype 0.01212 1.27 0.1026 
Year*Environment*Genotype 0.01965 1.42 0.0773 
Residual 0.1774 15.60 <.0001** 
**Highly significant at alpha 0.05 
*Significant at alpha 0.05 
NS Highly not significant at alpha 0.05; no value given 
 
 
Table 2.19. Variance parameter estimates for total avenanthramide concentration in spring oat. 
 
Variance Parameter Estimates 
Variance Parameter Estimate Z Value Pr > Z 
Year 0.5836 0.65 0.2594 
Environment 0 . NS 
Replication (Year*Environment) 0.004542 1.17 0.1211 
Genotype 0.2071 5.93 <.0001** 
Year*Environment 0.1642 1.38 0.0835 
Year*Genotype 0.02520 2.64 0.0041** 
Environment*Genotype 0.01471 1.66 0.0481* 
Year*Environment*Genotype 0.01970 1.59 0.0557 
Residual 0.1565 15.55 <.0001** 
**Highly significant at alpha 0.05 
*Significant at alpha 0.05 
NS Highly not significant at alpha 0.05; no value given 
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Table 2.20. Heritability estimates for avenanthramide 2c (AVN 2c), avenanthramide 2p (AVN 
2p), avenanthramide 2f (AVN 2f), and total avenanthramide (total AVN) concentration.  
 
 
Avenanthramide 
Narrow-Sense 
Heritability 
(Statistical Method) 
Narrow-Sense 
Heritability 
(Plant Breeding Method) 
AVN 2c 0.34 0.82 
AVN 2p 0.39 0.88 
AVN 2f 0.41 0.89 
Total AVN 0.37 0.86 
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FIGURES 
 
 
 
Figure 1.1. Chemical structure of avenanthramide 2c (AVN 2c), avenanthramide 2p (AVN 2p), 
and avenanthramide 2f (AVN 2f). 
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Figure 1.2. Biosynthesis pathway for the formation of avenanthramide 2c (AVN 2c), avenanthramide 2p (AVN 2p), and 
avenanthramide 2f (AVN 2f).(Yang et al., 2004) 
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Figure 2.1. High Performance Liquid Chromatography output for Illinois oat breeding line 11-5728 from the Barley Yellow Dwarf 
Virus nursery in Urbana in 2018. The peak label C5, with a retention time of 9.709, corresponds to avenanthramide 2c. The peak 
labeled C11, with a retention time of 13.589, corresponds to avenanthramide 2p. The peak label C12, with a retention time of 15.497, 
corresponds to avenanthramide 2f.  
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Figure 2.2. High Performance Liquid Chromatography output for oat cultivar BT1020-1-1 from the Monmouth, Illinois location in 
2018. The peak label C5, with a retention time of 9.844, corresponds to avenanthramide 2c. The peak labeled C11, with a retention 
time of 13.568, corresponds to avenanthramide 2p. The peak label C12, with a retention time of 15.468, corresponds to 
avenanthramide 2f. 
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Figure 2.3. High Performance Liquid Chromatography output for Illinois oat breeding line 12-7403 from Urbana, Illinois location in 
2018. The peak label C5, with a retention time of 9.812, corresponds to avenanthramide 2c. The peak labeled C11, with a retention 
time of 13.538, corresponds to avenanthramide 2p. The peak label C12, with a retention time of 15.446, corresponds to 
avenanthramide 2f. 
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Figure 2.4. High Performance Liquid Chromatography output for Illinois oat breeding line 12-8561 from the Urbana, Illinois location 
in 2018. The peak label C5, with a retention time of 9.841, corresponds to avenanthramide 2c. The peak labeled C11, with a retention 
time of 13.579, corresponds to avenanthramide 2p. The peak label C12, with a retention time of 15.487, corresponds to 
avenanthramide 2f. 
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Figure 2.5. A) Distribution of avenanthramide 2c (AVN 2c) concentrations from Barley Yellow 
Dwarf Virus (BYDV) samples averaged across 2017 and 2018. B) Distribution of 
avenanthramide 2p (AVN 2p) concentrations from BYDV samples averaged across 2017 and 
2018. C) Distribution of avenanthramide 2f (AVN 2f) concentrations from BYDV samples 
averaged across 2017 and 2018. D) Distribution of total avenanthramide (Total AVN) 
concentration from BYDV samples averaged across 2017 and 2018 with total AVN 
concentration being the summation of AVN 2c, 2p, and 2f. E) Distribution of BYDV severity 
ratings from BYDV nursery averaged across 2017 and 2018.  
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Figure 2.6. A) Distribution of avenanthramide 2c (AVN 2c) concentrations averaged across all environments and years. B) 
Distribution of avenanthramide 2p (AVN 2p) concentrations averaged across all environments and years. C) Distribution of 
avenanthramide 2f (AVN 2f) concentrations averaged across all environments and years. D) Distribution of total avenanthramide 
(Total AVN) concentration averaged across all environments and years with total AVN concentration being the summation of AVN 
2c, 2p, and 2f. 
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Figure 2.7. A) The year-environment-genotype effect on avenanthramide 2c (AVN 2c) 
concentration for 2017 plotted out by genotype and log AVN 2c concentration. B) The year-
environment-genotype effect on AVN 2c concentration for 2018 plotted out by genotype and log 
AVN 2c concentration.  
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Figure 2.8. The year-genotype effect for avenanthramide 2c (AVN 2c) concentration plotted out 
by genotype and log AVN 2c concentration. 
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Figure 2.9. The environment-genotype effect on avenanthramide 2c (AVN 2c) concentration 
plotted out by genotype and log AVN 2c concentration. 
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Figure 2.10. The year-genotype effect for avenanthramide 2p (AVN 2p) concentration plotted 
out by genotype and log AVN 2p concentration.
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Figure 2.11. The year-genotype effect for avenanthramide 2f (AVN 2f) concentration plotted out 
by genotype and log AVN 2f concentration. 
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Figure 2.12. The year-genotype effect for total avenanthramide (Total AVN) concentration 
plotted out by genotype and log total AVN concentration. 
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Figure 2.13. The environment-genotype effect on total avenanthramide (Total AVN) 
concentration plotted out by genotype and log total AVN concentration. 
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APPENDIX A: ADDITIONAL TABLES AND FIGURES 
Table A.1. Genotypic averages for Barley Yellow Dwarf Virus (BYDV) severity, avenanthramide 2c (AVN 2c), avenanthramide 2p 
(AVN 2p), avenanthramide 2f (AVN 2f), and total avenanthramide (Total AVN) concentrations based on data from 2017. 
 
 2017 
Genotype BYDV Severity 
AVN 2c 
(𝝁𝒈/𝒈) 
Rank 
AVN 2p 
(𝝁𝒈/𝒈) 
Rank 
AVN 2f 
(𝝁𝒈/𝒈) 
Rank 
Total AVN 
(𝝁𝒈/𝒈) 
Rank 
11-5728 3.5 14.09 4 17.25 2 20.75 1 52.10 1 
12-12821 5 11.34 10 23.59 1 12.62 7 47.55 2 
MN05155 5 12.60 6 16.09 3 15.48 3 44.17 3 
MN06203 7.5 9.80 18 14.38 5 18.51 2 42.70 4 
11-5748 4.5 15.81 2 12.10 7 13.11 5 41.02 5 
Reins 2.5 15.09 3 13.15 6 12.56 8 40.80 6 
09-6934 4 13.45 5 11.08 9 12.75 6 37.28 7 
12-7416 5 16.86 1 10.41 11 9.61 15 36.88 8 
SD110466 7 9.30 21 11.93 8 13.71 4 34.94 9 
12-12805 5.5 8.30 31 15.45 4 8.96 19 32.71 10 
12-5538 2.5 11.76 7 9.26 13 11.57 9 32.59 11 
11-2353 5 10.06 17 10.44 10 9.76 12 30.26 12 
12-5536 3.5 11.31 11 8.33 18 9.39 17 29.02 13 
12-7401 4 11.22 14 8.42 16 8.77 21 28.40 14 
08-9452 6 9.33 20 7.92 19 11.05 10 28.31 15 
12-1632 3.5 11.00 16 8.46 15 8.80 20 28.26 16 
12-7556 5 11.56 9 8.51 14 7.27 26 27.33 17 
Hazel 5.5 11.29 13 6.89 32 8.97 18 27.14 18 
MN07210 7 7.74 40 9.48 12 9.75 14 26.97 19 
09-2968 7 7.21 45 8.36 17 9.75 13 25.32 20 
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Table A.1. (con’t)          
          
BT1021-1-1 4.5 11.63 8 7.40 26 5.95 40 24.98 21 
06-8153 6 11.29 12 7.66 24 5.76 41 24.71 22 
11-2739 4.5 6.30 56 7.67 23 10.14 11 24.12 23 
Natty 7 7.91 37 7.68 22 8.39 23 23.98 24 
86-6404 3 11.18 15 6.48 38 6.32 35 23.97 25 
09-2756 4 9.04 22 6.65 36 7.74 24 23.43 26 
12-10931 5 8.98 23 7.16 28 7.16 27 23.30 27 
SD111972 3.5 8.82 24 7.82 20 6.52 34 23.16 28 
12-12427 5 8.18 32 7.33 27 7.51 25 23.02 29 
09-6937 5 6.51 52 7.07 30 9.43 16 23.01 30 
11-6469 6.5 8.04 36 7.75 21 7.13 28 22.92 31 
12-5508 2.5 9.56 19 6.26 40 6.06 39 21.87 32 
Saber 4.5 8.07 35 6.51 37 6.84 31 21.42 33 
MN06105 6.5 7.28 43 7.06 31 7.02 30 21.37 34 
12-5568 6 8.67 25 6.79 34 5.64 43 21.11 35 
12-1919 3.5 7.78 39 6.15 44 6.64 32 20.57 36 
MN08260 7.5 8.61 27 6.20 43 5.60 44 20.41 37 
MN06101 6.5 4.83 73 6.81 33 8.74 22 20.39 38 
SD111946 5.5 8.38 28 7.14 29 4.74 54 20.26 39 
11-7655 3.5 7.13 46 6.69 35 6.19 37 20.02 40 
12-3846 5.5 8.38 29 6.21 42 5.36 46 19.95 41 
12-7530 6 6.41 53 6.40 39 7.06 29 19.86 42 
12-7370 3.5 7.58 42 6.03 46 6.21 36 19.82 43 
Tack 4 6.92 47 7.54 25 4.79 53 19.25 44 
12-8561 4 6.71 49 6.06 45 6.15 38 18.92 45 
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Table A.1. (con’t)          
          
12-7403 5 8.66 26 5.16 49 4.97 50 18.79 46 
07-8721 3 6.09 57 6.23 41 5.65 42 17.96 47 
MN11211 6.5 6.36 55 4.86 51 6.59 33 17.81 48 
86-5698 5.5 8.35 30 4.35 57 4.91 52 17.61 49 
12-7430 3 8.08 34 4.75 53 4.44 56 17.27 50 
12-10307 3.5 7.63 41 5.43 48 4.10 63 17.15 51 
12-7074 3 7.86 38 4.87 50 4.13 62 16.85 52 
11-6459 3.5 8.16 33 4.69 55 3.83 67 16.68 53 
04-4410 2.5 6.62 50 4.72 54 5.27 47 16.62 54 
SD111939 5 6.75 48 5.45 47 4.10 64 16.30 55 
Corral 4 7.23 44 4.14 60 4.17 61 15.55 56 
10-5863 4 5.98 59 4.35 58 5.05 48 15.38 57 
08-2934 5.5 6.39 54 4.14 61 4.22 60 14.75 58 
11-7150 6 5.55 65 3.83 65 4.99 49 14.36 59 
SD111753 7.5 5.11 67 4.85 52 4.29 58 14.26 60 
08-10563 5.5 6.55 51 3.60 69 3.60 70 13.75 61 
08-2010 5 5.73 63 3.79 66 4.05 65 13.56 62 
10-9872 5.5 5.86 61 4.39 56 3.20 73 13.45 63 
12-7208 6.5 5.59 64 4.16 59 3.62 69 13.36 64 
IL-2901 2 4.65 77 3.44 74 4.93 51 13.02 65 
08-9442 4.5 5.96 60 4.07 62 2.83 81 12.87 66 
MN06120 5 4.23 82 4.06 63 4.56 55 12.85 67 
11-6458 4 5.99 58 3.73 67 3.03 74 12.75 68 
Clintland-64 8 5.06 70 3.11 79 4.41 57 12.58 69 
P0714A1-29-2 5 4.74 76 3.56 70 3.95 66 12.25 70 
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Table A.1. (con’t)          
          
BT1020-1-1 4 2.89 93 3.49 71 5.50 45 11.88 71 
10-2656 3.5 5.06 69 3.46 73 3.21 72 11.73 72 
08-9435 2 5.84 62 3.49 72 2.31 90 11.64 73 
SD031128 6.5 3.95 86 3.37 76 4.25 59 11.56 74 
12-1266 4 3.67 89 3.89 64 3.71 68 11.28 75 
02-8663 5 5.47 66 3.17 77 2.53 85 11.17 76 
MN11140 7 4.74 75 3.16 78 2.88 79 10.78 77 
09-5508 3 4.76 74 3.01 81 3.00 75 10.77 78 
09-2838 2.5 4.65 78 2.62 85 3.24 71 10.50 79 
08-6344 4.5 5.07 68 2.76 84 2.58 83 10.41 80 
Spurs 3.5 4.15 84 3.63 68 2.63 82 10.41 81 
07-8720 6 3.98 85 3.37 75 2.93 77 10.29 82 
12-5532 3 4.58 79 2.50 87 2.94 76 10.03 83 
11-7728 4 4.92 72 2.43 89 2.52 86 9.88 84 
12-9020 3 4.30 81 3.09 80 2.32 89 9.71 85 
11-6852 5 4.33 80 2.87 82 2.42 87 9.62 86 
12-7166 6.5 4.93 71 2.42 90 2.23 91 9.58 87 
11-5534 7.5 3.83 87 2.48 88 2.92 78 9.22 88 
09-5737 2.5 3.76 88 2.86 83 2.55 84 9.17 89 
Buckskin 4 4.22 83 2.60 86 1.65 96 8.47 90 
12-6448 3.5 3.43 90 2.08 93 2.87 80 8.38 91 
09-5745 4 3.11 91 2.17 91 2.37 88 7.65 92 
10-9867 5 2.93 92 1.96 94 2.02 92 6.92 93 
Excel 2.5 2.75 95 2.15 92 1.81 94 6.71 94 
Ogle 5.5 2.76 94 1.72 95 1.90 93 6.38 95 
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Table A.1. (con’t)          
          
09-3929 6 2.67 96 1.49 97 1.71 95 5.87 96 
Blaze 4 2.31 97 1.56 96 1.33 97 5.20 97 
09-1126 4.5 1.62 98 1.24 98 1.05 99 3.84 98 
11-6317 4.5 1.34 99 0.82 100 1.05 98 3.21 99 
08-7031 5 1.19 100 0.82 99 0.89 100 2.91 100 
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Table A.2. Genotypic averages for avenanthramide 2c (AVN 2c), avenanthramide 2p (AVN 2p), avenanthramide 2f (AVN 2f), and 
total avenanthramide (Total AVN) concentrations based on data from 2018. 
 
 2018 
Genotype BYDV Severity AVN 2c 
(𝝁𝒈/𝒈) 
Rank AVN 2p 
(𝝁𝒈/𝒈) 
Rank AVN 2f 
(𝝁𝒈/𝒈) 
Rank Total AVN 
(𝝁𝒈/𝒈) 
Rank 
11-5728 5.0 42.50 3 47.86 2 71.85 1 162.21 1 
09-6934 4.5 45.85 2 38.32 5 41.27 4 125.44 2 
11-5748 4.0 36.97 9 36.62 7 45.33 3 118.92 3 
12-12821 5.0 30.52 15 54.35 1 32.28 10 117.16 4 
12-7401 5.0 45.96 1 34.13 8 29.74 12 109.83 5 
MN05155 3.0 27.42 17 41.57 4 40.81 5 109.79 6 
MN06203 4.5 17.28 47 38.27 6 48.20 2 103.75 7 
11-7655 2.0 22.83 28 33.49 9 39.92 6 96.23 8 
Reins 4.5 31.88 12 30.37 10 32.48 9 94.74 9 
11-6459 7.5 39.70 4 29.88 11 20.88 25 90.46 10 
12-12805 4.0 22.58 29 42.77 3 24.57 16 89.93 11 
09-2968 6.5 31.17 13 28.88 12 28.80 13 88.85 12 
12-7416 5.5 38.41 6 24.75 18 21.53 22 84.69 13 
12-5538 7.0 29.94 16 24.95 17 28.47 14 83.35 14 
11-6458 5.5 39.52 5 25.33 16 18.41 32 83.27 15 
09-6937 3.5 19.61 38 26.87 14 35.37 7 81.86 16 
12-7556 6.0 37.86 7 22.64 21 21.33 24 81.83 17 
SD110466 7.0 17.97 46 28.73 13 34.67 8 81.37 18 
12-5536 3.0 24.32 23 26.36 15 30.43 11 81.11 19 
12-7430 5.5 35.74 10 22.48 22 19.50 28 77.71 20 
12-7403 6.5 37.03 8 21.00 25 18.99 31 77.02 21 
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Table A.2. (con’t)          
          
11-6469 5.0 26.89 18 23.23 19 24.03 19 74.16 22 
12-1632 3.5 26.62 19 23.00 20 24.45 17 74.07 23 
12-10931 5.0 23.83 24 21.85 23 27.58 15 73.26 24 
12-10307 5.0 31.11 14 21.15 24 16.02 47 68.28 25 
11-7728 7.0 32.83 11 17.06 43 16.16 45 66.05 26 
Natty 5.0 21.27 33 20.96 26 21.61 21 63.84 27 
06-8153 4.5 25.19 21 18.88 35 17.87 37 61.94 28 
12-7370 6.0 25.72 20 17.92 38 18.05 35 61.70 29 
12-7074 5.0 23.46 25 19.73 31 18.36 33 61.55 30 
12-5508 3.0 23.20 27 18.06 37 19.79 27 61.04 31 
10-2656 2.5 15.82 56 20.19 28 24.08 18 60.09 32 
09-2756 6.0 21.23 34 17.65 41 20.45 26 59.33 33 
12-7208 3.5 19.94 36 19.48 33 19.02 29 58.44 34 
MN06105 2.5 18.06 45 20.78 27 18.31 34 57.15 35 
Saber 5.5 20.14 35 17.42 42 19.01 30 56.57 36 
MN07210 4.5 14.70 64 19.21 34 22.43 20 56.33 37 
SD111939 3.0 21.68 30 20.15 29 13.90 56 55.73 38 
SD111753 5.5 19.18 42 18.87 36 17.63 39 55.68 39 
07-8720 5.0 24.61 22 16.18 48 14.68 50 55.48 40 
SD111946 5.0 21.39 32 19.71 32 13.74 57 54.83 41 
12-12427 6.0 19.34 40 19.93 30 14.59 52 53.87 42 
IL-2901 3.5 15.16 61 16.37 46 21.49 23 53.02 43 
09-5508 4.0 19.59 39 15.90 49 16.85 42 52.34 44 
11-2353 5.0 18.13 44 16.70 44 17.28 40 52.10 45 
12-3846 3.5 19.33 41 16.53 45 14.56 53 50.42 46 
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Table A.2. (con’t)          
          
12-8561 4.5 15.24 60 17.91 39 15.70 48 48.85 47 
86-6404 6.0 23.35 26 13.73 54 11.13 73 48.22 48 
MN06120 5.0 15.47 59 16.28 47 16.15 46 47.90 49 
BT1021-1-1 3.5 18.93 43 14.43 53 13.72 58 47.08 50 
MN06101 4.0 11.38 82 17.65 40 17.00 41 46.03 51 
08-6344 4.0 21.65 31 12.42 64 11.43 69 45.50 52 
04-4410 1.0 16.16 55 14.75 52 14.39 54 45.30 53 
Hazel 5.5 17.13 49 11.11 74 16.77 43 45.02 54 
02-8663 6.5 19.65 37 13.66 57 11.56 68 44.86 55 
12-5568 5.0 15.78 57 14.88 51 12.34 63 43.00 56 
10-9872 4.5 17.18 48 13.67 56 11.97 65 42.82 57 
12-1266 4.5 16.59 53 12.80 59 13.31 59 42.69 58 
12-7530 6.5 17.09 51 12.76 61 12.07 64 41.92 59 
08-9452 4.5 11.98 80 12.18 66 17.72 38 41.88 60 
86-5698 5.0 12.53 77 10.87 75 17.93 36 41.33 61 
10-5863 3.5 14.71 63 12.58 62 14.00 55 41.29 62 
11-7150 5.0 14.77 62 11.22 72 14.93 49 40.92 63 
09-5737 4.5 16.81 52 12.25 65 11.80 66 40.86 64 
08-2010 4.0 16.43 54 11.27 71 12.64 61 40.34 65 
11-2739 3.0 10.87 87 12.77 60 16.34 44 39.97 66 
07-8721 6.0 14.02 67 12.46 63 12.57 62 39.04 67 
MN08260 5.0 13.12 71 13.68 55 11.41 70 38.21 68 
11-6852 4.5 17.11 50 10.36 78 10.30 78 37.76 69 
08-9442 3.0 14.44 66 11.97 68 10.23 79 36.65 70 
10-9867 3.5 10.50 89 11.16 73 14.61 51 36.27 71 
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Table A.2. (con’t)          
          
Excel 5.5 9.48 93 15.12 50 11.10 74 35.70 72 
11-5534 5.5 13.61 69 11.37 70 10.58 77 35.56 73 
SD111972 2.5 12.84 73 12.98 58 9.44 85 35.26 74 
12-1919 2.0 12.54 75 10.22 79 11.76 67 34.53 75 
09-2838 3.0 12.27 79 10.05 80 11.08 75 33.40 76 
MN11140 6.0 10.32 90 11.72 69 11.30 72 33.34 77 
09-5745 6.5 15.70 58 8.85 87 8.79 87 33.34 78 
08-9435 2.5 12.32 78 12.00 67 8.17 92 32.49 79 
Corral 3.5 13.92 68 8.98 85 9.10 86 32.01 80 
P0714A1-29-2 4.0 10.83 88 10.50 77 10.14 80 31.46 81 
12-5532 3.0 10.91 86 9.12 84 11.38 71 31.42 82 
08-2934 4.5 12.54 76 8.61 89 9.83 82 30.98 83 
08-10563 5.0 12.87 72 9.60 81 8.32 90 30.79 84 
Tack 5.0 10.27 91 10.66 76 9.74 84 30.67 85 
12-7166 6.0 14.62 65 7.98 94 7.55 94 30.15 86 
12-6448 3.0 11.16 84 8.77 88 9.76 83 29.69 87 
Clintland-64 8.0 11.22 83 8.45 91 9.86 81 29.53 88 
Spurs 3.0 10.99 85 9.30 83 8.42 89 28.71 89 
MN11211 6.5 9.15 94 8.89 86 10.66 76 28.71 90 
Buckskin 5.0 13.19 70 9.49 82 5.93 96 28.61 91 
09-3929 4.5 11.62 81 7.86 95 7.90 93 27.38 92 
12-9020 4.0 12.68 74 8.55 90 5.44 98 26.68 93 
BT1020-1-1 6.5 5.16 100 8.23 92 13.29 60 26.67 94 
Ogle 5.0 9.82 92 8.03 93 8.25 91 26.10 95 
SD031128 5.0 7.01 99 6.65 98 8.51 88 22.17 96 
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Table A.2. (con’t)          
          
08-7031 7.0 9.02 95 6.82 97 5.83 97 21.67 97 
Blaze 2.0 7.97 96 6.47 99 6.99 95 21.43 98 
09-1126 6.5 7.57 97 7.43 96 5.26 99 20.27 99 
11-6317 5.0 7.17 98 3.92 100 4.23 100 15.32 100 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
92 
 
Table A.3. Genotypic averages for avenanthramide 2c (AVN 2c), avenanthramide 2p (AVN 2p), avenanthramide 2f (AVN 2f), and 
total avenanthramide (Total AVN) concentrations based on combined data from 2017 and 2018. 
 
 2 Year Average 
Genotype BYDV Severity AVN 2c 
(𝝁𝒈/𝒈) 
Rank AVN 2p 
(𝝁𝒈/𝒈) 
Rank AVN 2f 
(𝝁𝒈/𝒈) 
Rank Total AVN 
(𝝁𝒈/𝒈) 
Rank 
11-5728 4.3 29.59 3 33.95 2 48.62 1 112.16 1 
09-6934 4.3 31.12 1 25.94 6 28.30 5 85.37 2 
11-5748 4.3 27.35 5 25.47 7 30.69 3 83.51 3 
12-12821 5.0 20.93 13 38.97 1 22.45 10 82.35 4 
MN05155 4.0 20.68 14 29.99 4 29.30 4 79.96 5 
MN06203 6.0 13.88 41 27.41 5 34.71 2 76.00 6 
12-7401 4.5 30.17 2 22.44 9 20.21 13 72.82 7 
Reins 3.5 24.25 8 22.55 8 23.43 9 70.22 8 
12-12805 4.8 16.09 27 30.35 3 17.47 16 63.92 9 
12-7416 5.3 28.61 4 18.23 13 16.11 20 62.96 10 
11-7655 2.8 15.69 28 21.31 10 24.59 6 61.59 11 
12-5538 4.8 21.67 12 17.82 16 20.79 12 60.28 12 
09-2968 6.8 20.28 16 19.55 12 20.14 14 59.97 13 
SD110466 7.0 13.63 43 20.33 11 24.19 7 58.15 14 
12-5536 3.3 18.40 20 18.17 14 20.86 11 57.43 15 
12-7556 5.5 25.91 6 16.22 19 14.94 22 57.06 16 
09-6937 4.3 13.66 42 17.87 15 23.58 8 55.11 17 
11-6459 5.5 23.93 9 17.28 17 12.35 38 53.57 18 
12-10931 5.0 17.89 22 15.97 21 19.41 15 53.28 19 
12-1632 3.5 19.52 18 16.39 18 17.34 17 53.25 20 
11-6458 4.8 24.28 7 15.51 22 11.42 43 51.21 21 
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Table A.3. (con’t)          
          
11-6469 5.8 18.32 21 16.20 20 16.35 19 50.87 22 
12-7430 4.3 23.17 10 14.42 26 12.65 36 50.24 23 
12-7403 5.8 22.84 11 13.08 33 11.98 39 47.90 24 
Natty 6.0 15.20 32 14.93 23 15.60 21 45.72 25 
12-10307 4.3 20.44 15 14.00 28 10.60 47 45.04 26 
06-8153 5.3 18.87 19 13.78 30 12.36 37 45.02 27 
12-5508 2.8 17.00 25 12.70 36 13.54 28 43.24 28 
09-2756 5.0 15.69 29 12.65 37 14.67 25 43.01 29 
MN07210 5.8 11.53 53 14.79 24 16.67 18 42.99 30 
12-7370 4.8 17.47 24 12.52 40 12.67 35 42.66 31 
11-2353 5.0 14.46 36 13.85 29 13.86 27 42.17 32 
12-7074 4.0 16.37 26 12.97 34 11.89 40 41.23 33 
MN06105 4.5 13.16 45 14.54 25 13.18 32 40.89 34 
Saber 5.0 14.65 35 12.46 42 13.48 30 40.59 35 
11-7728 5.5 20.15 17 10.41 52 9.96 52 40.52 36 
12-12427 5.5 14.38 37 14.33 27 11.44 42 40.16 37 
10-2656 3.0 10.93 59 12.58 38 14.59 26 38.11 38 
SD111939 4.0 14.89 33 13.47 31 9.44 56 37.81 39 
SD111946 5.3 14.88 34 13.42 32 9.24 62 37.55 40 
86-6404 4.5 17.82 23 10.44 51 8.94 64 37.20 41 
IL-2901 2.8 10.96 58 11.20 45 14.86 23 37.02 42 
SD111753 6.5 12.79 47 12.50 41 11.57 41 36.85 43 
12-3846 4.5 14.35 38 11.84 43 10.38 50 36.57 44 
Hazel 5.5 14.21 39 9.00 63 12.87 33 36.08 45 
BT1021-1-1 4.0 15.28 30 10.91 47 9.84 54 36.03 46 
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Table A.3. (con’t)          
          
12-7208 5.0 12.76 48 11.82 44 11.32 45 35.90 47 
08-9452 5.3 10.77 63 10.25 55 14.69 24 35.71 48 
12-8561 4.3 11.36 54 12.52 39 11.36 44 35.24 49 
07-8720 5.5 15.23 31 10.36 53 9.34 60 34.94 50 
MN06101 5.3 8.41 83 12.72 35 13.25 31 34.38 51 
09-5508 3.5 12.85 46 10.04 57 10.55 48 33.44 52 
12-5568 5.5 12.55 49 11.20 46 9.30 61 33.05 53 
11-2739 3.8 8.79 81 10.45 50 13.52 29 32.76 54 
04-4410 1.8 11.83 51 10.19 56 10.25 51 32.27 55 
MN06120 5.0 10.36 71 10.73 48 10.88 46 31.97 56 
86-5698 5.3 10.86 62 8.26 69 12.72 34 31.84 57 
12-7530 6.3 11.75 52 9.58 59 9.56 55 30.89 58 
MN08260 6.3 11.07 56 10.28 54 8.77 67 30.12 59 
SD111972 3.0 11.01 57 10.64 49 8.11 68 29.76 60 
02-8663 5.8 13.20 44 8.89 64 7.46 76 29.55 61 
08-6344 4.3 14.11 40 8.03 71 7.41 77 29.55 62 
10-5863 3.8 10.74 64 8.84 65 9.93 53 29.51 63 
10-9872 5.0 12.04 50 9.45 60 7.99 69 29.47 64 
07-8721 4.5 10.41 69 9.63 58 9.42 58 29.46 65 
11-7150 5.5 10.58 67 7.86 73 10.41 49 28.85 66 
12-1266 4.3 10.72 65 8.75 66 8.95 63 28.41 67 
12-1919 2.8 10.38 70 8.37 68 9.43 57 28.19 68 
09-5737 3.5 10.88 61 7.98 72 7.60 71 26.46 69 
08-9442 3.8 10.59 66 8.38 67 6.87 83 25.84 70 
Tack 4.5 8.75 82 9.24 61 7.49 74 25.48 71 
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Table A.3. (con’t)          
          
08-2010 4.5 10.48 68 7.11 77 7.86 70 25.46 72 
11-6852 4.8 11.30 55 6.95 80 6.72 85 24.97 73 
Corral 3.8 10.88 60 6.78 82 6.86 84 24.52 74 
MN11211 6.5 7.88 87 7.06 78 8.81 66 23.76 75 
08-2934 5.0 9.75 75 6.58 85 7.28 79 23.60 76 
11-5534 6.5 9.16 77 7.33 76 7.09 81 23.59 77 
MN11140 6.5 7.79 89 7.83 74 7.47 75 23.08 78 
08-10563 5.3 10.00 73 6.87 81 6.17 88 23.05 79 
08-9435 2.3 9.38 76 8.13 70 5.51 92 23.01 80 
09-2838 2.8 8.81 80 6.67 84 7.51 73 22.99 81 
10-9867 4.3 7.06 92 6.98 79 8.89 65 22.93 82 
P0714A1-29-2 4.5 8.06 85 7.34 75 7.32 78 22.73 83 
Excel 4.0 6.42 94 9.23 62 6.87 82 22.52 84 
12-5532 3.0 8.04 86 6.11 87 7.54 72 21.70 85 
09-5745 5.3 9.98 74 5.81 90 5.87 89 21.66 86 
Clintland-64 8.0 8.14 84 5.78 91 7.13 80 21.05 87 
12-7166 6.3 10.22 72 5.45 94 5.13 93 20.80 88 
Spurs 3.3 7.88 88 6.72 83 5.79 90 20.39 89 
12-6448 3.3 7.65 90 5.73 92 6.62 86 20.00 90 
Buckskin 4.5 9.12 78 6.35 86 3.99 97 19.46 91 
BT1020-1-1 5.3 4.02 100 5.86 89 9.40 59 19.28 92 
12-9020 3.5 8.87 79 6.07 88 4.02 96 18.96 93 
Ogle 5.3 6.99 93 5.51 93 5.71 91 18.21 94 
09-3929 5.3 7.55 91 4.96 96 5.09 94 17.60 95 
SD031128 5.8 5.62 95 5.16 95 6.57 87 17.35 96 
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Table A.3. (con’t)          
          
Blaze 3.0 5.14 96 4.02 98 4.16 95 13.32 97 
09-1126 5.5 4.87 98 4.62 97 3.35 99 12.80 98 
08-7031 6.0 5.11 97 3.82 99 3.36 98 12.29 99 
11-6317 4.8 4.52 99 2.51 100 2.79 100 9.81 100 
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Figure A.1. A) The year-environment effect on avenanthramide 2c (AVN 2c) concentration for 
2017 plotted out by genotype and log AVN 2c concentration. B) The year-environment effect on 
AVN 2c concentration for 2018 plotted out by genotype. 
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Figure A.2. A) The year-environment-genotype effect on avenanthramide 2p (AVN 2p) 
concentration for 2017 plotted out by genotype and log AVN 2p concentration. B) The year-
environment-genotype effect on AVN 2p concentration for 2018 plotted out by genotype and log 
AVN 2p concentration.  
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Figure A.3. The environment-genotype effect on avenanthramide 2p (AVN 2p) concentration 
plotted out by genotype and log AVN 2p concentration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.4. A) The year-environment effect on avenanthramide 2p (AVN 2p) concentration for 
2017 plotted out by genotype and log AVN 2p concentration. B) The year-environment effect on 
AVN 2p concentration for 2018 plotted out by genotype and log AVN 2p concentration.  
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Figure A.5. A) The year-environment-genotype effect on avenanthramide 2f (AVN 2f) 
concentration for 2017 plotted out by genotype and log AVN 2f concentration. B) The year-
environment-genotype effect on AVN 2f concentration for 2018 plotted out by genotype and log 
AVN 2f concentration.  
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Figure A.6. The environment-genotype effect on avenanthramide 2f (AVN 2f) concentration 
plotted out by genotype and log AVN 2f concentration. 
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Figure A.7. The year-environment effect on avenanthramide 2f (AVN 2f) concentration for 2017 
plotted out by genotype and log AVN 2f concentration. B) The year-environment effect on AVN 
2f concentration for 2018 plotted out by genotype. 
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Figure A.8. A) The year-environment-genotype effect on total avenanthramide (Total AVN) 
concentration for 2017 plotted out by genotype and log total AVN concentration. B) The year-
environment-genotype effect on total AVN concentration for 2018 plotted out by genotype and 
log total AVN concentration.  
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Figure A.9. A) The year-environment effect on total avenanthramide (Total AVN) concentration 
for 2017 plotted out by genotype and log total AVN concentration. B) The year-environment 
effect on total AVN concentration for 2018 plotted out by genotype and log total AVN 
concentration.  
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APPENDIX B: BARLEY YELLOW DWARF VIRUS STUDY CODE 
SAS code used in the evaluation of correlations between Barley Yellow Dwarf tolerance, avenanthramide concentration. Special thank 
you to Dr. Carrie Butts-Wilmsmeyer for her guidance in writing this code. 
 
 
Title "BYDV"; 
data byd; set GxE;***deleting MON & UN locations to look at just avenanthramide data from inoculated BYBV 
environment***; 
if Env= "MON" then delete; 
if Env= "UN" then delete; 
*proc print data=byd (obs=5); run; 
 
Title "BYDV Transformed Aven 2C"; 
proc mixed data=byd covtest; 
class  Year Rep Geno; 
model logc=/ solution outp=residsCtbyd;***getting mu out for BLUP calculations & outputing residuals***; 
random Year Rep(Year) Geno Year*Geno/solution;***getting out random effects for BLUP calculations***; 
run;  
proc univariate data=residsCtbyd plots normal;***testing normality***; 
var resid; run; quit; 
proc glm data=residsCtbyd; 
class Year Rep Geno; 
model resid=Geno; 
means Geno/ hovtest=bf; run; quit;***testing constant variance***; 
 
***Plot graphics***; 
symbol1 interpol=join value=squarefilled color=red height=1;***creating plot graphics***; 
symbol2 interpol=join value=trianglefilled color=blue height=1; 
legend1 label=none value=(tick=1 "2017" tick=2 "2018" tick=3 "Urbana") frame; 
axis1 label=(h=2 color=black justify=center 'Genotype'); 
axis2 label=(h=2 color=black angle=90 justify=center 'Avn 2c'); 
axis3 label=(h=2 color=black angle=90 justify=center 'Avn 2p'); 
axis4 label=(h=2 color=black angle=90 justify=center 'Avn 2f'); 
axis5 label=(h=2 color=black angle=90 justify=center 'Avn 2total'); 
axis6 label=(h=2 color=black angle=90 justify=center 'BYDV Severity Rating'); 
data bydblup;***inputing byd blups dataset***; 
infile "C:\Users\dmichls2\Desktop\Master's Project\datasets for analysis\byd blup sas file.csv" firstobs=2 
dlm="," lrecl=1500; 
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input geno$ c17 c18 p17 p18 f17 f18 t17 t18 bydrate17 bydrate18 c p f total rating; 
run; 
*proc print data=bydblup (obs=5); run; quit; 
***2-way interaction profile plot***; 
proc gplot data=bydblup; 
plot (c17 c18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis2; 
title "Year x Genotype"; run;end;title;quit; 
 
Title "BYDV Transformed Aven 2p"; 
proc mixed data=byd covtest; 
class Year Rep Geno; 
model logp=/solution outp=residsPtbyd;***getting mu out for BLUP calculations & outputing residuals***; 
random Year Rep(Year) Geno Year*Geno/solution;***getting out random effects for BLUP calculations***; 
run; 
proc univariate data=residsPtbyd plots normal;***testing normality***; 
var resid; run; quit; 
proc glm data=residsPtbyd; 
class year rep geno; 
model resid=geno; 
means geno/ hovtest=bf; run; quit;***testing constant variance***; 
***2-way interaction profile plot***; 
proc gplot data=bydblup; 
plot (p17 p18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis3; 
title "Year x Genotype"; run;end;title;quit; 
 
Title "BYDV Transformed Aven 2f"; 
proc mixed data=byd covtest; 
class year Rep Geno; 
model logf=/solution outp=residsFtbyd;***getting mu out for BLUP calculations & outputing residuals***; 
random year Rep(year) Geno year*Geno/solution;***getting out random effects for BLUP calculations***; 
run; 
proc univariate data=residsFtbyd plots normal;***testing normality***; 
var resid; run; quit; 
proc glm data=residsftbyd; 
class year rep geno; 
model resid=geno; 
means geno / hovtest=bf; run; quit;***testing constant variance***; 
***2-way interaction profile plot***; 
proc gplot data=bydblup; 
plot (f17 f18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis4; 
title "Year x Genotype"; run;end;title;quit; 
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Title "BYDV Transformed Aven 2total"; 
proc mixed data=byd covtest; 
class year Rep Geno; 
model logt=/solution outp=residsTtbyd;***getting mu out for BLUP calculations & outputing residuals***; 
random year Rep(year) Geno year*geno/solution;***getting out random effects for BLUP calculations***; 
run; 
proc univariate data=residsTtbyd plots normal;***testing normality***; 
var resid; run; quit; 
proc glm data=residsTtbyd; 
class year rep geno; 
model resid=geno; 
means geno/ hovtest=bf; run; quit;***testing constant variance***; 
*proc sort data=residsTt; by resid; run; quit;***sorting residuals to identify outliers***; 
*proc print data=residsTt; run; quit; 
***2-way interaction profile plot***; 
proc gplot data=bydblup; 
plot (t17 t18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis5; 
title "Year x Genotype"; run;end;title;quit; 
 
Title "BYDV ratings"; 
data bydrating; 
infile "C:\Users\dmichls2\Desktop\Master's Project\datasets for analysis\BYDV ratings.csv" firstobs=2 
dlm="," lrecl=1500; 
input plot rep entry geno$ year rating; 
run; 
proc mixed data=bydrating covtest; 
class year Rep Geno; 
model rating=/solution outp=residsRate;***getting mu out for BLUP calculations & outputing residuals***; 
random year Rep(year) Geno year*geno/solution;***getting out random effects for BLUP calculations***; 
run; 
proc univariate data=residsRate plots normal;***testing normality***; 
var resid; run; quit; 
proc glm data=residsRate; 
class year rep geno; 
model resid=geno; 
means geno / hovtest=bf; run; quit;title;***testing constant variance***; 
***2-way interaction profile plot***; 
proc gplot data=bydblup; 
plot (bydrate17 bydrate18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis6; 
title "Year x Genotype"; run;end;title;quit; 
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***BYDV BLUPs correlation***; 
Title "BYDV Correlations"; 
proc corr data=bydblup;***getting correlations between blups***; 
var c17 p17 f17 t17 bydrate17;run; quit; 
proc corr data=bydblup;***getting correlations between blups***; 
var c18 p18 f18 t18 bydrate18;run; quit; 
proc corr data=bydblup; 
var c p f total rating;run;quit; 
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APPENDIX C: DIVERSITY STUDY CODE 
SAS code used in the evaluation of the environmental impact seen on avenanthramide concentration and avenanthramide 
concentration heritability. Special thank you to Dr. Carrie Butts-Wilmsmeyer for her guidance in writing this code. 
 
 
data GxE;***inputing dataset***; 
infile "C:\Users\dmichls2\Desktop\Master's Project\datasets for analysis\Datefile1.csv" firstobs=2 dlm="," 
lrecl=1500; 
input Env$ Year Entry LabID$ Rep Geno$ c p f total;run; 
Title "GxE data"; 
data GxE; set GxE; 
logc= log(c+1/6);***transforming data to meet assumptions***; 
logp= log(p+1/6); 
logf= log(f+1/6); 
logt= log(total+1/6);run;  
*proc print data=GxE (obs=5); run; title; 
 
*Transformed Data*; 
Title "Transformed Aven 2C"; 
proc mixed data=GxE covtest; 
class Year Env Rep Geno; 
model logc=/ solution outp=residsCt;***getting mu out for BLUP calculations & outputing residuals***; 
random Year Env Rep(Year*Env) Geno Year*Env Year*Geno Env*Geno Year*Env*Geno/solution;run;***getting out 
random effects for BLUP calculations***; 
proc univariate data=residsCt plots normal;***testing normality***; 
var resid; run; quit; 
proc glm data=residsCt; 
class year env rep geno; 
model resid=geno; 
means geno / hovtest=bf;run;***testing constant variance***; 
*model resid=env*geno; 
*means env*geno/ hovtest=bf;run; 
*model resid=year*geno; 
*means year*geno/ hovtest=bf;run; 
*proc sort data=residsCt;by resid;run;quit; 
*proc print data=residsCt;run;quit;title 
 
***Inputing all BLUPs for diversity study***; 
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data GEblups; 
infile "C:\Users\dmichls2\Desktop\Master's Project\datasets for analysis\BLUP-sas file.csv" firstobs=2 
dlm="," lrecl=1500; 
input geno$ cYEi17 cYEGi17 cYEm17 cYEGm17 cYEu17 cYEGu17 cYEi18 cYEGi18 cYEm18 cYEGm18 cYEu18 cYEGu18 cYG17 
cYG18 cEGi cEGm cEGu pYEi17 pYEGi17 pYEm17 pYEGm17 pYEu17 pYEGu17 pYEi18 pYEGi18 pYEm18 pYEGm18 pYEu18 
pYEGu18 pYG17 pYG18 pEGi pEGm pEGu fYEi17 fYEGi17 fYEm17 fYEGm17 fYEu17 fYEGu17 fYEi18 fYEGi18 fYEm18 
fYEGm18 fYEu18 fYEGu18 fYG17 fYG18 fEGi fEGm fEGu tYEi17 tYEGi17 tYEm17 tYEGm17 tYEu17 tYEGu17 tYEi18 
tYEGi18 tYEm18  tYEGm18 tYEu18 tYEGu18 tYG17 tYG18 tEGi tEGm tEGu cG pG fG tG;run; 
*proc print data=GEblups (obs=5);run; 
symbol1 interpol=join value=squarefilled color=red height=1;***creating plot graphics***; 
symbol2 interpol=join value=trianglefilled color=blue height=1; 
symbol3 interpol=join value=dot color=green height=1; 
legend1 label=none value=(tick=1 "BYDV Nursery" tick=2 "Monmouth" tick=3 "Urbana") frame; 
legend2 label=none value=(tick=1 "2017" tick=2 "2018") frame; 
axis1 w=2 label=(h=2 color=black justify=center 'Genotype'); 
axis2 order=(-1 to 6 by 1) label=(h=2 color=black angle=90 justify=center 'log Avn 2c Concentration') 
minor=(n=4); ***3-way axes***; 
axis3 order=(-1 to 6 by 1) label=(h=2 color=black angle=90 justify=center 'log Avn 2p Concentration') 
minor=(n=4); 
axis4 order=(-1 to 6 by 1) label=(h=2 color=black angle=90 justify=center 'log Avn 2f Concentration') 
minor=(n=4); 
axis5 order=(-1 to 6 by 1) label=(h=2 color=black angle=90 justify=center 'log Total Avn Concentration') 
minor=(n=4); 
axis6 order=(0 to 5 by 0.5) label=(h=2 color=black angle=90 justify=center 'log Avn 2c Concentration') 
minor=(n=4);***YxE axes***; 
axis7 order=(0 to 5 by 0.5) label=(h=2 color=black angle=90 justify=center 'log Avn 2p Concentration') 
minor=(n=4); 
axis8 order=(0 to 5 by 0.5) label=(h=2 color=black angle=90 justify=center 'log Avn 2f Concentration') 
minor=(n=4); 
axis9 order=(0 to 5 by 0.5) label=(h=2 color=black angle=90 justify=center 'log Total Avn Concentration') 
minor=(n=4); 
axis10 order=(0 to 5 by 0.5) label=(h=2 color=black angle=90 justify=center 'log Avn 2c Concentration') 
minor=(n=4);***YxG axes***; 
axis11 order=(0 to 5 by 0.5) label=(h=2 color=black angle=90 justify=center 'log Avn 2p Concentration') 
minor=(n=4); 
axis12 order=(0 to 5 by 0.5) label=(h=2 color=black angle=90 justify=center 'log Avn 2f Concentration') 
minor=(n=4); 
axis13 order=(0 to 5 by 0.5) label=(h=2 color=black angle=90 justify=center 'log Total Avn Concentration') 
minor=(n=4); 
axis14 order=(0 to 5 by 1) label=(h=2 color=black angle=90 justify=center 'log Avn 2c Concentration') 
minor=(n=4);***ExG axes***; 
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axis15 order=(0 to 5 by 1) label=(h=2 color=black angle=90 justify=center 'log Avn 2p Concentration') 
minor=(n=4); 
axis16 order=(0 to 5 by 1) label=(h=2 color=black angle=90 justify=center 'log Avn 2f Concentration') 
minor=(n=4); 
axis17 order=(0 to 5 by 1) label=(h=2 color=black angle=90 justify=center 'log Total Avn Concentration') 
minor=(n=4); 
***Three-way interaction profile plot 2017***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (cYEGi17 cYEGm17 cYEGu17)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis2; 
title "2017 Year x Environment x Genotype"; run; end; title;quit; 
***Three-way interaction profile plot 2018***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (cYEGi18 cYEGm18 cYEGu18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis2; 
title "2018 Year x Environment x Genotype"; run; end; title;quit; 
***Two-way interaction YxE profile plot 2017***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (cYEi17 cYEm17 cYEu17)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis6; 
title "2017 Year x Environment"; run; end; title;quit; 
***Two-way interaction YxE profile plot 2018***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (cYEi18 cYEm18 cYEu18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis6; 
title "2018 Year x Environment"; run; end; title;quit; 
***Two-way interaction YxG profile plot***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (cYG17 cYG18)*geno/overlay legend=legend2 haxis=axis1 vaxis=axis10; 
title "Year x Genotype"; run; end; title;quit; 
***Two-way interaction ExG profile plot***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (cEGi cEGm cEGu)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis14; 
title "Environment x Genotype"; run; end; title;quit; 
 
 
Title "Transformed Aven 2p"; 
proc mixed data=GxE covtest; 
class Year Env Rep Geno; 
model logp=/solution outp=residsPt;***getting mu out for BLUP calculations & outputing residuals***; 
random Year Env Rep(Year*Env) Geno Year*Env Year*Geno Env*Geno Year*Geno*Env/solution;run;***getting out 
random effects for BLUP calculations***; 
proc univariate data=residsPt plots normal;***testing normality***; 
var resid; run; quit; 
proc glm data=residsPt; 
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class year env rep geno; 
model resid=geno; 
means geno/ hovtest=bf;run;***testing constant variance***; 
*model resid=env*geno; 
*means env*geno/ hovtest=bf;run; 
*model resid=year*geno; 
*means year*geno/ hovtest=bf;run; 
*proc sort data=residsPt;by resid;run;quit; 
*proc print data=residsPt;run;quit;title; 
***Three-way interaction profile plot 2017***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (pYEGi17 pYEGm17 pYEGu17)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis3; 
title "2017 Year x Environment x Genotype"; run; end; title;quit; 
***Three-way interaction profile plot 2018***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (pYEGi18 pYEGm18 pYEGu18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis3; 
title "2018 Year x Environment x Genotype"; run; end; title;quit; 
***Two-way interaction YxE profile plot 2017***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (pYEi17 pYEm17 pYEu17)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis7; 
title "2017 Year x Environment"; run; end; title;quit; 
***Two-way interaction YxE profile plot 2018***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (pYEi18 pYEm18 pYEu18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis7; 
title "2018 Year x Environment"; run; end; title;quit; 
***Two-way interaction YxG profile plot***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (pYG17 pYG18)*geno/overlay legend=legend2 haxis=axis1 vaxis=axis11; 
title "Year x Genotype"; run; end; title;quit; 
***Two-way interaction ExG profile plot***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (pEGi pEGm pEGu)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis15; 
title "Environment x Genotype"; run; end; title;quit; 
 
 
Title "Transformed Aven 2f"; 
proc mixed data=GxE covtest; 
class Year Env Rep Geno; 
model logf=/solution outp=residsFt;***getting mu out for BLUP calculations & outputing residuals***; 
random Year Env Rep(Year*Env) Geno Year*Env Year*Geno Env*Geno Year*Env*Geno/solution;run;***getting out 
random effects for BLUP calculations***; 
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proc univariate data=residsFt plots normal;***testing normality***; 
var resid; run; quit; 
proc glm data=residsFt; 
class year env rep geno; 
model resid=geno; 
means geno / hovtest=bf;run;***testing constant variance***; 
*model resid=env*geno; 
*means env*geno/ hovtest=bf;run; 
*model resid=year*geno; 
*means year*geno/ hovtest=bf;run; 
*proc sort data=residsFt;by resid;run;quit; 
*proc print data=residsFt;run;quit;title; 
***Three-way interaction profile plot 2017***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (fYEGi17 fYEGm17 fYEGu17)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis4; 
title "2017 Year x Environment x Genotype"; run; end; title;quit; 
***Three-way interaction profile plot 2018***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (fYEGi18 fYEGm18 fYEGu18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis4; 
title "2018 Year x Environment x Genotype"; run; end; title;quit; 
***Two-way interaction YxE profile plot 2017***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (fYEi17 fYEm17 fYEu17)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis8; 
title "2017 Year x Environment"; run; end; title;quit; 
***Two-way interaction YxE profile plot 2018***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (fYEi18 fYEm18 fYEu18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis8; 
title "2018 Year x Environment"; run; end; title;quit; 
***Two-way interaction YxG profile plot***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (fYG17 fYG18)*geno/overlay legend=legend2 haxis=axis1 vaxis=axis12; 
title "Year x Genotype"; run; end; title;quit; 
***Two-way interaction ExG profile plot***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (fEGi fEGm fEGu)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis16; 
title "Environment x Genotype"; run; end; title;quit; 
 
 
Title "Transformed Aven 2total"; 
proc mixed data=GxE covtest; 
class Year Env Rep Geno; 
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model logt=/solution outp=residsTt;***getting mu out for BLUP calculations & outputing residuals***; 
random Year Env Rep(Year*Env) Geno Year*Env Year*Geno Env*Geno Year*Env*Geno/solution;run;***getting out 
random effects for BLUP calculations***; 
proc univariate data=residsTt plots normal;***testing normality***; 
var resid; run; quit; 
proc glm data=residsTt; 
class year env rep geno; 
model resid=geno; 
means geno / hovtest=bf;run;***testing constant variance***; 
*model resid=env*geno; 
*means env*geno/ hovtest=bf;run; 
*model resid=year*geno; 
*means year*geno/ hovtest=bf;run; 
*proc sort data=residsTt;by resid;run;quit; 
*proc print data=residsTt;run;quit;title; 
***Three-way interaction profile plot 2017***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (tYEGi17 tYEGm17 tYEGu17)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis5; 
title "2017 Year x Environment x Genotype"; run; end; title;quit; 
***Three-way interaction profile plot 2018***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (tYEGi18 tYEGm18 tYEGu18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis5; 
title "2018 Year x Environment x Genotype"; run; end; title;quit; 
***Two-way interaction YxE profile plot 2017***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (tYEi17 tYEm17 tYEu17)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis9; 
title "2017 Year x Environment"; run; end; title;quit; 
***Two-way interaction YxE profile plot 2018***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (tYEi18 tYEm18 tYEu18)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis9; 
title "2018 Year x Environment"; run; end; title;quit; 
***Two-way interaction YxG profile plot***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (tYG17 tYG18)*geno/overlay legend=legend2 haxis=axis1 vaxis=axis13; 
title "Year x Genotype"; run; end; title;quit; 
***Two-way interaction ExG profile plot***; 
proc gplot data=GEblups;***plotting BLUPs by environment to break apart gxe interaction***; 
plot (tEGi tEGm tEGu)*geno/overlay legend=legend1 haxis=axis1 vaxis=axis17; 
title "Environment x Genotype"; run; end; title;quit; 
***Correlations between avenanthramides***; 
proc corr data=GEblups; 
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var cG pG fG tG; run; quit; 
proc corr data=GEblups; 
var cYG17 pYG17 fYG17 tYG17;run;quit; 
proc corr data=GEblups; 
var cYG18 pYG18 fYG18 tYG18;run;quit;   
proc corr data=GEblups; 
var cYG17 pYG17 fYG17 tYG17 cYG18 pYG18 fYG18 tYG18;run;quit;  
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APPENDIX D: PROTOCOLS 
Avenanthramide protocol for sample post-harvest grain processing, sample extraction, and high 
performance liquid chromatography (HPLC). 
 
 
 
Avenanthramide Protocol 
 
Post-harvest Processing 
 
1. Dehull oat grains and save groats. Hulls can be discarded. Use impact dehuller at farm if 
possible. Need a sample of ~20g for the impact dehuller to work properly. If sample is 
>20g then Dehull by hand. Store dehulled grain at -20°C. 
2. Grind saved groats with coffee grinder for ~10 sec and then pass through a 0.5mm 
screen (#35 screen at Dr. Juvik’s lab). 
3. Weigh out an aliquot of ~0.15g of ground groat sample in a 2.0mL centrifuge tube. Store 
ground and weighed samples at -20°C until extraction. 
Avenanthramide Extraction 
Notes (Read BEFORE beginning extractions). 
*I ran batches of 25 samples and the extraction process took ~8 hours for one batch. 
*Turn on shaking incubator table and set to 50°C before starting extractions to allow to reach 
appropriate temperature 
*Turn on speedvac to warm up before starting extractions. Speedvac should be set so RC is OFF, 
drying rate high is ON, and Vapornet Cryopumping is ON. When samples are drying speedvac 
should be run on manual. (All these settings are switches on the front of the speedvac.) The 
condensation jar should be checked periodically and emptied if around 
1
3
 the way full. (How full 
the condensation jar is can affect the drying rate. 
*The HPLC will need to be purged to clean off column. It is good to do this while the samples 
are resuspending if possible. Run 100% solvent B through HPLC for at least 10 minutes or until 
chromatogram is relatively flat. Then run 100% solvent A through HPLC for at least 10 minutes 
or until chromatogram is relatively flat. 
*It took ~20 hours to run a batch of 25 samples through the HPLC. 
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4. Pipette 1.5mL of extraction buffer, which is 80% EtOH (made with 10mM NaH2PO4, pH 
2.8), into 2.0mL centrifuge tube containing weighed aliquot of ground groat sample. 
5. Place 2.0mL centrifuge tube containing weighed aliquot of ground groat sample and 
extraction buffer into a shaking incubator at 50°C for 20 minutes. 
6. After extraction 2.0mL centrifuge tube containing weighed aliquot of ground groat 
sample and extraction buffer is for 7 minutes at 3000rpm @ 23°C in a table top 
centrifuge. 
7. Carefully pour off supernatant from 2.0mL centrifuge tube containing weighed aliquot 
of ground groat sample and extraction buffer into 15mL tube. 
8. Repeat steps 4-7 two more times 
9. Place 15mL tube containing the pooled supernatant into rotary evaporate in speedvac 
under a vacuum @ room temperature until dry. This took ~3-5hrs. Dry samples can be 
stored for up to 2 weeks at -20°C.  
10. Pipette 600𝜇L of 100% MeOH into the 15mL tube containing the evaporated 
supernatant sample. Place capped 15mL centrifuge tube containing the evaporated 
supernatant sample and MeOH into shaker at room temperature for 30 minutes. 
Centrifuge tube must be help in place. I used masking tape. Make sure cap on 15mL 
tube is tight. 
11. Filter resuspended sample through 0.2μm PTFE membrane into 300µL insert 2mL then 
place insert into 2.0mL HPLC vial. Cap HPLC vial.   
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HPLC Protocol 
12. Avenanthramide analysis conducted using HPLC on a 4.6 x 100mm, 2.7μm C18 column 
using a diode array spectrophotometer detector with detection at 340nm @ room 
temperature. 
a. Mobil phase of buffer A (water with 5% acetonitrile & 0.1% formic acid) and 
buffer B (acetonitrile with 0.1% formic acid) using a linear gradient of 15 to 26% 
B over 35 minutes at a flow rate of 1.0mL/minute and 10μL injection at room 
temperature. (HPLC method I used is saved as AVENA7 at Dr. Juvik’s) 
Solvent Preparation 
Phosphate Buffer (10mM 𝑁𝑎𝐻2𝑃𝑂4) 
 Add 1.3799g 𝑁𝑎𝐻2𝑃𝑂4 to 1000mL of deionized 𝐻2𝑂. Should completely dissolve 
with shaking. I used a 1L bottle. 
 Add small drops of phosphoric acid using a disposable pipette until a pH of 2.7 is 
reached. 
Extraction Buffer  
 Add 800mL of 100% EtOH and 200mL of Phosphate Buffer to 1L bottle 
Solvent A 
 Add 50mL Acetonitrile and 1.136 mL of 88% formic acid to 2000mL graduated 
cylinder. 
 Fill graduated cylinder to 2000mL with filtered 𝐻2𝑂. 
 Pour into 2L bottle. 
*Note: You will go through Solvent A quickly. I would suggest making larger volumes for 
stock is containers for storage are available. 
Solvent B 
 Add 1.136mL of 88% formic acid to 1000mL graduate cylinder. 
 Fill graduated cylinder to 1000mL with filtered 𝐻2𝑂. 
 Pour into 1L bottle. 
 
